Latest / INSPIRE STORY / #075_ STORY INSPIRE: Cancer Doctor Reveals: The Common Food That Could Be Making Cancer Worse
Transcript
- 0:00Speaker 1: Cancer is very preventable. When the medical establishment acknowledges what
- 0:03Speaker 1: I know about this disorder, what's causing it, and what
- 0:06Speaker 1: we're not doing to prevent it or treat it, it
- 0:08Speaker 1: will be recognized as the greatest tragedy in the history
- 0:10Speaker 1: of medicine.
- 0:11Speaker 2: Thomas Seyfried is a professor of biology, genetics, and biochemistry who.
- 0:15Speaker 1: Has dedicated the past 30 years gathering scientific evidence on
- 0:18Speaker 1: what could be the true origin and prevention of cancer.
- 0:22Speaker 1: Cancer is getting worse, and there's no major advance in
- 0:24Speaker 1: reducing death rates, and I can speak to the reasons
- 0:27Speaker 1: for that. All major cancer research centers think cancer is
- 0:31Speaker 1: a genetic disease.
- 0:32Speaker 2: You believe otherwise.
- 0:33Speaker 1: It's not whether you believe, it's what the data tell us.
- 0:35Speaker 1: And the evidence is massive to support that cancer is
- 0:38Speaker 1: a metabolic disorder. And the problem is we're doing everything
- 0:40Speaker 1: we possibly can in our lifestyle to induce it. The
- 0:44Speaker 1: scientific evidence is there. Like, for example, we know that
- 0:46Speaker 1: cancer was extremely rare in African tribes that were living
- 0:50Speaker 1: according to the traditional ways. But when modern lifestyle entered
- 0:53Speaker 1: into their societies, cancer out of control. We even did
- 0:56Speaker 1: a study on dogs. We know that wolves in the
- 0:58Speaker 1: wild don't die from cancer, but cancer is the number
- 1:01Speaker 1: one killer of domestic dogs.
- 1:03Speaker 2: Why?
- 1:04Speaker 1: It's because of our lifestyle issues. And a lot of
- 1:07Speaker 1: us are doing things without the knowledge that it would
- 1:09Speaker 1: put us at risk. But with metabolic therapy, you can
- 1:11Speaker 1: use it as both a prevention and a treatment. And
- 1:13Speaker 1: we're seeing more and more of hormonal cancer patients outliving
- 1:17Speaker 1: their predictability because of this. And let me tell you
- 1:19Speaker 1: one thing and remember it. If you do metabolic therapy,
- 1:21Speaker 1: you can actually reduce risk for cancer. You can take
- 1:24Speaker 1: away the fear.
- 1:25Speaker 2: And when you say metabolic therapy, tell me what those
- 1:27Speaker 2: things are.
- 1:27Speaker 1: Number one.
- 1:31Speaker 2: Before this episode starts, I have a small favor to
- 1:33Speaker 2: ask from you. Two months ago, 74% of people that
- 1:36Speaker 2: watched this channel didn't subscribe. We're now down to 69%.
- 1:41Speaker 2: My goal is 50%. So if you've ever liked any
- 1:44Speaker 2: of the videos we've posted, if you like this channel,
- 1:46Speaker 2: can you do me a quick favor and hit the
- 1:48Speaker 2: subscribe button? It helps this channel more than you know,
- 1:50Speaker 2: and the bigger the channel gets, as you've seen, the
- 1:52Speaker 2: bigger the guests get. Thank you and enjoy this episode.
- 1:59Speaker 2: Professor Seyfried. If someone walks up to you on the
- 2:01Speaker 2: street and they know nothing about science, they know nothing
- 2:04Speaker 2: about medicine, et cetera, and they asked you, what do
- 2:07Speaker 2: you do and why do you do it? How would
- 2:08Speaker 2: you respond?
- 2:09Speaker 1: I'm a professor of biology at Boston College. So in
- 2:13Speaker 1: that role, I spend a lot of my time working
- 2:16Speaker 1: with undergraduates and graduate students in training them to be
- 2:20Speaker 1: scientific literate in various aspects of biology. The research program
- 2:26Speaker 1: that we have at the university is also focused on
- 2:31Speaker 1: understanding how to manage cancer better, how it originates and
- 2:35Speaker 1: how to prevent it.
- 2:37Speaker 2: How much of a problem is cancer globally? What are
- 2:40Speaker 2: the sort of headline statistics on the macro view of
- 2:43Speaker 2: cancer for someone that really doesn't know?
- 2:45Speaker 1: Yeah, well, it's getting worse. I can't say, it's in
- 2:49Speaker 1: the millions. I know precisely what's going on in this
- 2:53Speaker 1: country because the American Cancer Society every year distributes the
- 2:58Speaker 1: data on cancer. We have almost 2 million new cases
- 3:04Speaker 1: diagnosed per year in the United States. And we have 1,700
- 3:09Speaker 1: people a day dying from cancer in the United States,
- 3:14Speaker 1: which comes to about 70 people per hour in the
- 3:17Speaker 1: United States. Now, when I went to China, I looked
- 3:21Speaker 1: at some numbers there, and it was 8,000 people a
- 3:23Speaker 1: day are dying from cancer. Obviously, the population is so
- 3:28Speaker 1: much larger. And I don't know what it is in
- 3:31Speaker 1: the UK. I mean, we'd have to go to their
- 3:33Speaker 1: cancer registries. But what we do know is that it's
- 3:37Speaker 1: supposed to be a lot worse by 2050 than it
- 3:40Speaker 1: is today. So there seems to be no reduction in
- 3:43Speaker 1: death suffering for this disease. And I can speak to
- 3:48Speaker 1: the reasons for that. But right now, I would say
- 3:51Speaker 1: it's a global epidemic of cancer. It's not getting better.
- 3:56Speaker 1: It's getting worse. More people are dying from it. There's
- 3:58Speaker 1: no major advance in reducing death rates. So it's a
- 4:02Speaker 1: great tragedy. And when we understand what's causing it and
- 4:08Speaker 1: what we're not doing to prevent it or treat it,
- 4:10Speaker 1: it'll be recognized as the singular greatest tragedy in the
- 4:14Speaker 1: history of medicine worldwide. When they come to know what
- 4:18Speaker 1: I know about this disorder and then they realize what
- 4:21Speaker 1: we've been doing, in a misdirected way, it will be
- 4:25Speaker 1: recognized as the greatest tragedy in the history of medicine.
- 4:29Speaker 2: What types of cancer are people dying from? What is
- 4:32Speaker 2: the most popular types of cancer for men and women?
- 4:34Speaker 1: Well, it's always been lung cancer, pretty much for men
- 4:37Speaker 1: and women. Lung cancer has always been the number one,
- 4:40Speaker 1: but we have pancreatic breast cancer, colon cancer. These are
- 4:44Speaker 1: all on the rise. Colon cancer is on the rise.
- 4:46Speaker 1: Pancreatic cancer is on the rise in this country. I
- 4:50Speaker 1: can't speak for other countries specifically, They may vary slightly
- 4:55Speaker 1: due to diet and lifestyle issues. But lung cancer has
- 4:57Speaker 1: always been recognized as the number one cancer.
- 5:01Speaker 2: How many people in the United States then, based on
- 5:04Speaker 2: the statistics, would develop cancer?
- 5:06Speaker 1: Well, it seems to increase every year. So it's kind
- 5:09Speaker 1: of a moving target. It doesn't seem to go down.
- 5:13Speaker 1: What it is today, I don't know. But what I
- 5:16Speaker 1: do know is the numbers of people that are dying
- 5:18Speaker 1: each day. Because the American Cancer Society comes out with
- 5:23Speaker 1: I think it's 612,000 people will die this year, 2024,
- 5:28Speaker 1: from cancer in this year. So divide it by 365,
- 5:33Speaker 1: and it comes out to just about 1,700 people a day.
- 5:36Speaker 1: Divide that number by 24, and you get about 70
- 5:39Speaker 1: people an hour, based on the numbers provided to us
- 5:43Speaker 1: from the American Cancer Society. When they say we've made
- 5:47Speaker 1: major advances in cancer incidences, right? So in the 1990s,
- 5:53Speaker 1: they instituted the anti-smoking campaigns. So today, if you read,
- 5:58Speaker 1: they say we have reduced cancer deaths by 31% or 32%. Wow,
- 6:03Speaker 1: that sounds really impressive. So what they do is they
- 6:07Speaker 1: take the number. This is what the American Cancer Society
- 6:11Speaker 1: has done. It's published in their papers. OK, if we
- 6:14Speaker 1: didn't stop smoking in the 90s and everybody continued to smoke,
- 6:19Speaker 1: the trajectory would be very, very high. Because we stopped smoking,
- 6:25Speaker 1: we have 33% lower death than if we didn't stop smoking.
- 6:29Speaker 1: But the trajectory is continuing to increase, maybe not as
- 6:33Speaker 1: steep as it would have been had we continued to smoke.
- 6:36Speaker 1: So it was clearly a prevention. It had nothing to
- 6:39Speaker 1: do with a treatment. It had to do with prevention
- 6:41Speaker 1: that was giving Oh, we've made major advances in reducing
- 6:46Speaker 1: cancer death rates. Yeah, because people stopped smoking. Many, many people,
- 6:51Speaker 1: more people would have died had they not smoked. So
- 6:53Speaker 1: we have people that are not real people. We're just
- 6:57Speaker 1: looking at what would have happened if we didn't stop smoking.
- 7:01Speaker 2: What are the leading causes of death worldwide in terms
- 7:04Speaker 2: of diseases? I hear that heart disease is number one.
- 7:09Speaker 1: I think that heart disease is number one. Cancer is
- 7:12Speaker 1: number two.
- 7:13Speaker 2: Okay. And there are many different types of cancer, right?
- 7:16Speaker 2: There's hundreds of different forms of cancer.
- 7:20Speaker 1: If you look under the electron microscope or a correction,
- 7:23Speaker 1: even a light microscope, this is how most cancers are
- 7:25Speaker 1: diagnosed by light microscopy. You look under the microscope and
- 7:29Speaker 1: you see a bunch of cells that are dysmorphic in
- 7:32Speaker 1: the way they look and then they all have genetic
- 7:34Speaker 1: defects and all this kind of stuff. But they all
- 7:37Speaker 1: have one thing in common. They depend on a fermentation,
- 7:41Speaker 1: energy without oxygen. So all cancers are a singular type
- 7:44Speaker 1: of disease. It's just that they happen in different tissues.
- 7:47Speaker 1: But when you look at the underlying problem, they're all very,
- 7:50Speaker 1: very similar. They can't live without a fermentation, which means
- 7:53Speaker 1: energy without oxygen. So that's the common pathophysiological problem in
- 7:57Speaker 1: all cancers, whether it's a colon, brain, breast, bladder, skin, lung.
- 8:04Speaker 1: We've looked at all these cancers and they're all essentially
- 8:08Speaker 1: using the same mechanism to grow out of control.
- 8:11Speaker 2: So what is that fermentation you mentioned?
- 8:13Speaker 1: Fermentation is energy without oxygen.
- 8:15Speaker 2: What does that mean?
- 8:17Speaker 1: We breathe air and we exhale CO2 and water vapor.
- 8:21Speaker 1: And those are the waste products of the food that
- 8:23Speaker 1: we eat. Everything is broken down and combusted in our
- 8:26Speaker 1: mitochondria of the cell. And the waste products are CO2
- 8:30Speaker 1: and water vapors. Those are the waste products. But If
- 8:33Speaker 1: you and I were to stop breathing for any particular
- 8:37Speaker 1: time period, our bodies would fill up with lactic acid
- 8:42Speaker 1: and succinic acid, like if we were to have a
- 8:44Speaker 1: heart attack or when somebody has a heart attack. They
- 8:47Speaker 1: don't die instantly. If they're there for five or seven
- 8:52Speaker 1: minutes without oxygen, they may die because the brain dies.
- 8:55Speaker 1: But if you can get the heart to beat again
- 8:57Speaker 1: and get oxygen back in the system, you can come
- 9:00Speaker 1: alive again. But when we have that massive interruption of
- 9:04Speaker 1: oxygen into our body. The cells immediately turn on these
- 9:12Speaker 1: ancient pathways to get energy without oxygen for a short
- 9:16Speaker 1: period of time. And that's the sugar glucose, which is
- 9:19Speaker 1: already in our bloodstream from the food we eat, and
- 9:22Speaker 1: the amino acid glutamine, which is an amino acid in
- 9:26Speaker 1: our bloodstreams. Highest level of amino acid is the glutamine.
- 9:30Speaker 1: These two fuels are now burned for energy, obtain energy
- 9:34Speaker 1: without oxygen. These pathways upregulate, and you can get ATP,
- 9:40Speaker 1: which is energy, to keep you alive for a short
- 9:42Speaker 1: period of time. But your bloodstream is filling up with
- 9:45Speaker 1: the waste products called lactic acid and succinic acid. Lactic
- 9:49Speaker 1: acid is coming from glucose to sugar, and succinic acid
- 9:53Speaker 1: is coming from the amino acid glutamine. And they build up,
- 9:56Speaker 1: and that tells you you're fermenting. You're getting energy without
- 9:59Speaker 1: oxygen because you not breathing. Very simple. You're not breathing,
- 10:02Speaker 1: but I'm not dead yet. Now, of course, if you
- 10:04Speaker 1: don't get it for very long, you die. It's just that. Now,
- 10:08Speaker 1: the other way you can stop oxygenation in our bodies
- 10:11Speaker 1: quickly is with the poison cyanide. So if we, God forbid,
- 10:17Speaker 1: we were to take cyanide, we'd be both dead within
- 10:19Speaker 1: a minute. Because our bodies are completely shut down of
- 10:24Speaker 1: energy from oxygen. Now here's the cancer cell. The cancer
- 10:28Speaker 1: cell can live in cyanide. Cyanide does not kill a tumor, okay?
- 10:35Speaker 1: Otto Warburg showed this a long time ago, and we've
- 10:37Speaker 1: also shown the same thing in our lab. Others have
- 10:40Speaker 1: shown this. The interesting thing is when you look at
- 10:42Speaker 1: cancer cells, Even in the presence of oxygen, even in oxygen,
- 10:46Speaker 1: they're throwing out lactic acid and succinic acid. What does
- 10:50Speaker 1: that mean? That means the organelle inside the cell that
- 10:55Speaker 1: generates energy is not efficient. It's inefficient. And the cells
- 10:59Speaker 1: are using ancient fermentation. And when I say ancient fermentation,
- 11:03Speaker 1: you have to realize the Earth is four and a
- 11:05Speaker 1: half billion years old. The organisms that existed on our
- 11:10Speaker 1: planet Two and a half billion years ago, we're all fermenters.
- 11:14Speaker 1: There was no oxygen in the atmosphere until the photosynthetic
- 11:16Speaker 1: bacteria started making oxygen. There were living cells. They had
- 11:20Speaker 1: no oxygen. And they were growing like crazy, unregulated growth,
- 11:25Speaker 1: just unregulated. What's going on here? And they would die
- 11:28Speaker 1: as soon as the fermentable fuels were dissipated. As they
- 11:31Speaker 1: gobbled up everything, they would just die. So they lived
- 11:33Speaker 1: as long as they could reproduce and have fermentation fuels.
- 11:37Speaker 1: The cancer cell in our body is doing nothing than
- 11:40Speaker 1: falling back on these ancient fermentation pathways that become accelerated,
- 11:45Speaker 1: upregulated in the tumor cell because the efficiency of the
- 11:49Speaker 1: energy coming from the mitochondria is now depleted. It's defective
- 11:54Speaker 1: in many different ways. So this is very clear. And
- 11:57Speaker 1: this happens in lung cancer, colon cancer. We've looked at
- 11:59Speaker 1: all the major cancers. And we found out these common
- 12:02Speaker 1: defects are seen in all the cancers. So they're all
- 12:06Speaker 1: very similar in their metabolism. They're very different in what
- 12:08Speaker 1: they look like under the microscope. Lung doesn't look like colon,
- 12:11Speaker 1: doesn't look like brain. They're very different genetically. They're all
- 12:14Speaker 1: different from each other, but they're all common in a
- 12:17Speaker 1: dependency on this ancient pathway of energy metabolism.
- 12:21Speaker 2: Can you take me back? You mentioned a guy called
- 12:24Speaker 2: Walt Wahlberg there.
- 12:25Speaker 1: Yeah.
- 12:25Speaker 2: Can you take me back on the journey that the
- 12:28Speaker 2: scientific community, or at least you have been on, to
- 12:30Speaker 2: arrive at the conclusion that the central sort of causal factor,
- 12:33Speaker 2: at least an indication of the causal factor of cancer
- 12:36Speaker 2: lies in this shift in energy systems. Where did this
- 12:40Speaker 2: understanding start in research?
- 12:42Speaker 1: Well, it started with Otto Warburg, for sure, in the 1920s.
- 12:46Speaker 1: The other linkage, before I tell you what Otto Warburg did,
- 12:49Speaker 1: because I was like everybody else, I thought cancer was
- 12:52Speaker 1: a genetic disease. And I heard about Warburg, didn't really
- 12:55Speaker 1: know what he was talking about or invested any time
- 12:59Speaker 1: thinking about what he said. But Lyndon Neblings, was a
- 13:03Speaker 1: PhD nursing student at Case Western Reserve University in Ohio.
- 13:08Speaker 1: And she took these two little hopeless kids, brain cancer.
- 13:12Speaker 1: We call hopeless cases when they have no predictability of
- 13:16Speaker 1: long-term survival. And she gave them a ketogenic diet, the
- 13:20Speaker 1: lower blood sugar. And she was able to rescue these kids.
- 13:25Speaker 1: One eventually died. The other one was lost to follow-up.
- 13:28Speaker 1: And she said her strategy was based on what Otto
- 13:31Speaker 1: Warburg had said about glucose and cancer. So then I said, Warburg?
- 13:35Speaker 1: I said, who the hell? Let me go back and
- 13:37Speaker 1: check out who this guy was and what he did.
- 13:39Speaker 1: Because I was seeing similar things in the mouse with
- 13:41Speaker 1: that drug. It was lower in glucose. And we were
- 13:45Speaker 1: shrinking these tumor cells. And we published a paper, one
- 13:49Speaker 1: of the first ever papers, linking that how high your
- 13:52Speaker 1: blood sugar is determines how fast your tumor will grow
- 13:55Speaker 1: in the mice. And now this has been replicated in
- 13:57Speaker 1: all human cancers. The higher your blood sugar, the faster
- 14:01Speaker 1: the tumor grows. The lower the blood sugar, the slower
- 14:03Speaker 1: the tumor grows. Undeniable for all different human mouse cancers.
- 14:07Speaker 2: Wow.
- 14:08Speaker 1: So Warburg had said this a long time ago, back
- 14:10Speaker 1: in the 1920s. He was taking slices of all kinds
- 14:15Speaker 1: of human and rat mouse tumors and slicing them up.
- 14:18Speaker 1: And he noticed something really strange about these cancers. They
- 14:22Speaker 1: take in less oxygen. compared to the normal tissue from
- 14:25Speaker 1: which they came. Wow, so they're kind of like oxygen deprived.
- 14:29Speaker 1: And they were throwing out this lactic acid waste product
- 14:32Speaker 1: that he was saying. And they were taking in so
- 14:35Speaker 1: much more glucose than the normal. So the normal cells
- 14:38Speaker 1: take in just a little bit of glucose, and they
- 14:40Speaker 1: can make tremendous energy from a tiny amount. This guy
- 14:43Speaker 1: was taking in huge amounts of glucose, but not fully
- 14:46Speaker 1: metabolizing it to CO2 and water, but dumping it out
- 14:50Speaker 1: as lactic acid, which is a a breakdown product of
- 14:53Speaker 1: glucose that is not fully metabolized in the cell. Wow,
- 14:57Speaker 1: he said, this is unbelievable. And then he did all
- 15:00Speaker 1: kinds of tissue. I looked at his data. It was unbelievable.
- 15:02Speaker 1: He was cutting humans, mice, rats, and seeing the same
- 15:05Speaker 1: thing over and over again. And he was saying the
- 15:10Speaker 1: origin of cancer has to do with something in the
- 15:13Speaker 1: ability of the mitochondrion, the organelle, to generate efficient energy
- 15:17Speaker 1: from oxygen.
- 15:18Speaker 2: So the mitochondria is the part of the cell that
- 15:21Speaker 2: creates energy?
- 15:22Speaker 1: It's the part of the cell that creates energy through
- 15:25Speaker 1: oxidative phosphorylation, which is burning energy using oxygen. Okay.
- 15:30Speaker 2: Okay.
- 15:31Speaker 1: So it's like an engine. It's an engine, a very
- 15:33Speaker 1: highly efficient engine. This is an organelle. You have to
- 15:36Speaker 1: realize we have the cell.
- 15:38Speaker 2: Yeah.
- 15:38Speaker 1: And we have a nucleus that everybody knows about, this nucleus.
- 15:41Speaker 1: And then we have all these little organelles in there.
- 15:43Speaker 1: We have lysosomes and we have the mitochondrion, which is
- 15:47Speaker 1: like a spaghetti network inside the cell. They fuse. It's
- 15:51Speaker 1: actually a second living cell. It's a second living organism
- 15:54Speaker 1: inside our cells.
- 15:55Speaker 2: And to simplify what they do, the mitochondria, they convert
- 15:59Speaker 2: oxygen and glucose into energy?
- 16:00Speaker 1: Yes, they combust energy. The foods that we eat have
- 16:05Speaker 1: carbon-hydrogen bonds, okay? And we break those down inside our mitochondria.
- 16:11Speaker 1: And when we break those bonds down, we create a
- 16:14Speaker 1: hydrogen gradient, and we dissipate that gradient through an impeller
- 16:18Speaker 1: mechanism that generates energy like crazy. It's unbelievable. Very efficient,
- 16:22Speaker 1: highly efficient. But the cancer cell has corruption in that system.
- 16:26Speaker 1: But it doesn't happen overnight. As Warburg said, if you
- 16:30Speaker 1: break that system too acutely and too fast, the cell
- 16:32Speaker 1: will die. It doesn't have the... So you have to
- 16:35Speaker 1: have two things to get from oxidative phosphorylation to energy
- 16:41Speaker 1: with minimal oxygen fermentation.
- 16:43Speaker 2: Sorry, just to keep it simple. From a normal cell
- 16:45Speaker 2: to a cancer cell.
- 16:46Speaker 1: From a normal cell to a cancer cell doesn't happen overnight.
- 16:49Speaker 2: Okay.
- 16:50Speaker 1: It's a chronic damage to the ability of that organelle
- 16:54Speaker 1: inside the cell to generate efficient energy. So all we
- 16:58Speaker 1: have to know with cancer is how are they growing
- 17:02Speaker 1: so rapidly? Why are they going out of control? How
- 17:04Speaker 1: come it's so hard to kill them? Because as long
- 17:07Speaker 1: as you have those fermentable fuels that drive this ancient
- 17:11Speaker 1: fermentation pathway, They will continue to grow. They're very hard
- 17:15Speaker 1: to kill.
- 17:16Speaker 2: And the fermenting fuels are glucose and- And glutamine. Glutamine. Yeah. Okay.
- 17:21Speaker 1: So here, let me tell you in a nutshell. Are
- 17:23Speaker 1: you ready? Brace yourself. Are you ready? I'm ready. Are
- 17:26Speaker 1: you braced? Are you braced?
- 17:28Speaker 2: Sufficiently braced.
- 17:29Speaker 1: He's sufficiently braced. Okay. So a solution to the cancer problem,
- 17:35Speaker 1: to manage cancer without toxicity, is to simultaneously restrict the
- 17:41Speaker 1: two fuels- that are needed to drive this dysregulated growth
- 17:45Speaker 1: while transitioning the whole body off to a fuel that
- 17:49Speaker 1: the tumor cells can't use, which is fatty acids and
- 17:52Speaker 1: ketone bodies. So when we take the cancer patients or
- 17:56Speaker 1: the mice, we put them into a calorie restriction, lowering
- 18:00Speaker 1: the blood sugar that I said is one half of
- 18:04Speaker 1: the two fuels. You can lower that down really, really low.
- 18:07Speaker 1: And then we use specific drugs to target the glutamine.
- 18:11Speaker 1: And together, we can selectively restrict the two fuels while
- 18:15Speaker 1: we transition the whole body over to ketones. We, as
- 18:19Speaker 1: a species, evolved to be in nutritional ketosis for the
- 18:23Speaker 1: majority of our existence as a species, like one and
- 18:26Speaker 1: a half million years. For centuries and centuries, thousands and
- 18:30Speaker 1: thousands of years, our species, you and me, our ancestors,
- 18:35Speaker 1: were always in a state of nutritional ketosis. Because there
- 18:38Speaker 1: was very few carbohydrates in the environment for them to
- 18:41Speaker 1: be consuming, right? So the cancer cell, the body, you
- 18:45Speaker 1: and I could, if we stopped eating and we took
- 18:47Speaker 1: a low-carbohydrate diet and just did water-only fasting, we would
- 18:50Speaker 1: get into nutritional ketosis, where the normal cells, our brain,
- 18:55Speaker 1: our kidneys, our heart, can be burning these ketone bodies
- 18:58Speaker 1: because they have a good mitochondria and they can burn
- 19:01Speaker 1: these fuels effectively. The tumor cells have a bad mitochondria.
- 19:04Speaker 1: They can't burn those fuels. They're dependent on glucose and glutamine.
- 19:07Speaker 1: we can replace glucose and glutamine with ketone bodies in
- 19:10Speaker 1: the normal cells of our... So we selectively marginalize these
- 19:13Speaker 1: tumor cells slowly over time. They slowly start to die,
- 19:18Speaker 1: the blood vessels disappear, and the body comes in and
- 19:21Speaker 1: dissolves them.
- 19:22Speaker 2: So for someone that has never heard the term keto before,
- 19:26Speaker 2: ketosis or ketones, in a simple way, what are ketones?
- 19:31Speaker 1: Ketones are water-soluble breakdown products of fatty acids, okay? They're beta-hydroxybutyrate, acetoacetate.
- 19:37Speaker 1: These are small molecules that are water-soluble. The liver throws
- 19:41Speaker 1: them out like crazy. Kidney a little bit, but mostly liver.
- 19:44Speaker 1: So as I told you earlier, when we don't eat,
- 19:50Speaker 1: you get anxious, mainly because our brains are addicted to glucose.
- 19:53Speaker 1: It's like cocaine and nicotine and whatever. You start getting
- 19:57Speaker 1: all antsy. I haven't eaten anything. What's going on? So
- 20:02Speaker 1: then once the body realizes you ain't going to eat anything,
- 20:06Speaker 1: we have to start mobilizing out of our fat resources.
- 20:09Speaker 1: And the fats go into the bloodstream as triglycerides, which
- 20:13Speaker 1: are three fatty acids attached to a glycerol backbone. They
- 20:17Speaker 1: go to the liver. The liver chops them up and
- 20:19Speaker 1: puts out these little water-soluble ketone bodies. The name ketone
- 20:25Speaker 1: body is kind of a weird thing from biochemistry, but
- 20:28Speaker 1: they're called ketone bodies. And they can supply the brain
- 20:32Speaker 1: with energy, the heart with energy. And not only that,
- 20:35Speaker 1: they're a super fuel. It's unbelievable. that mitochondria burns these ketones. Okay,
- 20:40Speaker 1: but their energy, remember I was talking about how energy
- 20:43Speaker 1: efficient the mitochondria become? When they burn ketones, they become
- 20:46Speaker 1: even more energy efficient. It's unbelievable how, they don't need
- 20:50Speaker 1: as much oxygen to generate more energy. That's why they,
- 20:53Speaker 1: my colleagues called, and some of the greats in the
- 20:57Speaker 1: biochemistry field called them super, super fuel, because you can
- 21:01Speaker 1: get more energy bang for buck burning a ketone body
- 21:04Speaker 1: than you can burning a pyruvate coming from glucose. or
- 21:07Speaker 1: even a fatty acid. And the biochemistry for that is interesting.
- 21:13Speaker 1: But the bottom line is when you transition away from
- 21:15Speaker 1: these fuels to keto, don't forget, we evolved. Our ancestors
- 21:19Speaker 1: were always in a state of ketosis. You get into
- 21:22Speaker 1: that state by consuming very few carbohydrates and having a
- 21:25Speaker 1: lot of energy. And this is the way our ancestors were.
- 21:28Speaker 2: So what can we learn from our ancestors about cancer?
- 21:31Speaker 2: How prevalent was cancer when we look back at our ancestors,
- 21:35Speaker 2: if they were often in a state of ketosis?
- 21:37Speaker 1: Yeah, well, it's hard to determine from skeletal records, but
- 21:42Speaker 1: I think we can look at modern man who live
- 21:48Speaker 1: according to their traditional ways. You know, Albert Schweitzer, the
- 21:54Speaker 1: great humanitarian physician, went to Africa and looked at Africans
- 21:57Speaker 1: that were living according to the traditional ways. He said,
- 22:01Speaker 1: one of the weirdest things, they don't have cancer. It's like, what?
- 22:04Speaker 1: The cancer was extremely rare. in Africans, Inuits living in
- 22:10Speaker 1: the areas, British when they came in looking at the
- 22:15Speaker 1: health conditions of folks that lived in the Arctic Circle.
- 22:18Speaker 1: Cancer was not there. They had other things, but they
- 22:20Speaker 1: didn't have cancer. Aboriginal folks. So it seems as though
- 22:25Speaker 1: our living, we can't go back 50,000 years ago because
- 22:30Speaker 1: we don't have people to examine. But we have people
- 22:32Speaker 1: to examine today. And that was one of the things
- 22:34Speaker 1: Schweitzer and several other physicians from Europe would go to Africa.
- 22:38Speaker 1: And they would look at some of these tribes that
- 22:40Speaker 1: were traditional. And they were saying, whoa, what's going on
- 22:43Speaker 1: with these Africans? How come they don't have cancer? But
- 22:45Speaker 1: when modern diet and lifestyle entered into their societies, cancer
- 22:50Speaker 1: out of control.
- 22:51Speaker 2: What about our other primate cousins?
- 22:54Speaker 1: Yeah. There's never been a documented case of breast cancer
- 22:59Speaker 1: in a female chimpanzee. and they're 98% similar to us
- 23:03Speaker 1: in gene and protein sequence. You know, what's going on
- 23:06Speaker 1: with that? Monkeys, they don't generally form cancer. They're eating.
- 23:11Speaker 1: They're not eating what we eat, okay? Don't forget, we
- 23:14Speaker 1: did not evolve to eat pork pies and Dunkin' Donuts,
- 23:19Speaker 1: jelly-filled donuts and pizzas. We did not. Our ancestors did
- 23:23Speaker 1: not eat this, right? We were killing and eating animals
- 23:26Speaker 1: As I said, we ate everything that walked, crawled, flew,
- 23:29Speaker 1: or swam on this planet became part of our diet.
- 23:32Speaker 1: We did not have donuts on every corner, delicatessens on
- 23:36Speaker 1: every corner. We evolved over this period of time, just
- 23:39Speaker 1: like our primate ancestors. The animals, chimps and gorillas and
- 23:45Speaker 1: things that you see in the zoos are fed their
- 23:48Speaker 1: natural diets as if they were living in their habitat,
- 23:51Speaker 1: their natural habitat, whether it was in South America, Africa,
- 23:54Speaker 1: or wherever it was. We're not throwing in jelly donuts
- 23:57Speaker 1: every day and pizza pie into the chimpanzee pen. And
- 24:01Speaker 1: as a matter of fact, I even went to the
- 24:03Speaker 1: zoo down here in Boston, Franklin Park Zoo, and also
- 24:07Speaker 1: at the San Diego Zoo. I said, how come you
- 24:11Speaker 1: guys don't give these guys, run down and get a
- 24:13Speaker 1: big pizza for these animals? Oh, no, it would be
- 24:15Speaker 1: animal cruelty. Their systems aren't geared for this. Well, neither
- 24:18Speaker 1: are we. We have an obesity epidemic. We have all
- 24:25Speaker 1: these different chronic diseases. Why? We didn't evolve to eat
- 24:28Speaker 1: all this crap that we're eating today. So what I've
- 24:31Speaker 1: told many people in these podcasts is that our food
- 24:34Speaker 1: science and technology and our society's technology has evolved so
- 24:38Speaker 1: much faster than our biology.
- 24:41Speaker 2: Can you explain to me, in simple terms, the role
- 24:43Speaker 2: that exercise is playing in staving off cancer?
- 24:46Speaker 1: Well, exercise lowers blood sugar. And it also lowers glutamine.
- 24:50Speaker 1: So the two fuels that are driving– now we can't
- 24:54Speaker 1: completely remove glutamine by exercise, that's for sure. But my
- 24:58Speaker 1: late good friend George Cahill published some papers on showing
- 25:01Speaker 1: how exercise could actually lower glutamine availability. So it's a
- 25:06Speaker 1: little bit of a push. But you're also– when you exercise,
- 25:10Speaker 1: you're burning and you're not eating a lot of carbs.
- 25:12Speaker 1: Your mitochondria are burning ketones, and the oxygenation from all
- 25:15Speaker 1: the exercise is keeping those mitochondria super healthy at their
- 25:19Speaker 1: highest level of energy efficiency.
- 25:22Speaker 2: So exercise— You're building muscle as well, aren't you?
- 25:24Speaker 1: Yeah, you're building— well, you can build muscle, but you're certainly
- 25:26Speaker 1: getting aerobic exercise. Oxygen is coming in, and you're burning ketones,
- 25:31Speaker 1: which I already told you is a super fuel. So
- 25:34Speaker 1: your body is super healthy. These bodies from the Paleolithic period,
- 25:39Speaker 1: these men were jacked. There was no obesity in these people.
- 25:42Speaker 1: They had tremendous energy. They're not dying from the things
- 25:45Speaker 1: that are killing us. They're dying from injuries and infections.
- 25:49Speaker 2: When you described this slow and gradual shift in the
- 25:53Speaker 2: cell as it moves to this sort of ancient system,
- 25:56Speaker 2: it sounded very gradual. So in my head, I thought, okay,
- 25:59Speaker 2: so does that mean that the cancer is a gradual
- 26:03Speaker 2: process that is kind of building up in me or
- 26:06Speaker 2: isn't building up in me based on the lifestyle decisions
- 26:09Speaker 2: I'm making and my environmental factors? right now? I'm trying
- 26:14Speaker 2: to say, does cancer start slowly, years before you've tried
- 26:19Speaker 2: to manage it?
- 26:20Speaker 1: Yeah, it is a gradual process, but it can be
- 26:22Speaker 1: impacted by several provocative agents from the microenvironment. Lack of exercise.
- 26:30Speaker 1: So we're not exercising nearly as much as our Paleolithic ancestors,
- 26:34Speaker 1: bar none, right? We have massive amounts of processed carbs
- 26:38Speaker 1: in our diets. We have a lot of emotional stress. mental,
- 26:43Speaker 1: emotional stress that's impacting negatively on our biology. We have
- 26:51Speaker 1: lack of sleep. Sleep, a lot of us, because we
- 26:55Speaker 1: have stresses, you have to have, when you put all
- 26:57Speaker 1: of these impactful things together in one person, you can
- 27:01Speaker 1: put yourself at risk for cancer, all of which will
- 27:04Speaker 1: damage and reduce the efficiency of mitochondria. And also the
- 27:10Speaker 1: joy of living Having friends and friendships and this kind
- 27:14Speaker 1: of thing reduces stress in a lot of different ways,
- 27:16Speaker 1: makes people enjoy getting up and having a nice day
- 27:20Speaker 1: rather than being depressed or these kinds of things. You
- 27:23Speaker 1: put all this together and you put yourself in a
- 27:27Speaker 1: diet and a lifestyle that puts you at risk for
- 27:29Speaker 1: damage to oxidative phosphorylation and the transition from one form
- 27:33Speaker 1: of energy to a fermentation energy.
- 27:35Speaker 2: And what I'm trying to understand, is that a gradual transition?
- 27:38Speaker 1: It's a gradual transition. You have to be able to
- 27:40Speaker 1: do that. And how long does it take for a colon,
- 27:44Speaker 1: a group of cells in a crypt of your colon
- 27:47Speaker 1: to transition from one stage to another? You have to
- 27:50Speaker 1: be constantly under stress, those cells in that organ. Now,
- 27:54Speaker 1: why somebody gets colon cancer, another person gets breast cancer,
- 27:57Speaker 1: another person gets bladder cancer, and some person gets a
- 27:59Speaker 1: brain cancer and all these different kinds of cancers. Whatever happened,
- 28:03Speaker 1: the process was causing a gradual disruption of oxidative phosphorylation,
- 28:09Speaker 1: oxidative respiration. and a gradual transition to a fermentation. Like
- 28:14Speaker 1: in the brain, the neurons rarely, if ever, get cancer.
- 28:18Speaker 1: But the glial cells that support neurons, they are usually
- 28:21Speaker 1: the source of the origin of cancer in the brain
- 28:24Speaker 1: for those kinds of cells. And you can look at
- 28:26Speaker 1: different cells, and some are more or less prone. And
- 28:28Speaker 1: why this guy got lung cancer from smoking cigarettes, this
- 28:31Speaker 1: guy got bladder cancer from smoking cigarettes. How did it
- 28:34Speaker 1: all start? It all started from a population of cells
- 28:38Speaker 1: in one of those organs having a chronic, not instant,
- 28:42Speaker 1: a chronic interruption of oxidative energy followed by an upregulation
- 28:47Speaker 1: of this fermentation energy.
- 28:49Speaker 2: So really we need to be thinking about all the
- 28:50Speaker 2: things that have caused dysfunction in the mitochondria.
- 28:52Speaker 1: Absolutely.
- 28:53Speaker 2: I want to get a list of the key things
- 28:55Speaker 2: that are associated with causing this dysfunction.
- 28:57Speaker 1: Okay, carcinogens.
- 28:58Speaker 2: Okay, so carcinogens.
- 28:59Speaker 1: Yeah, and you know, there's many, asbestos, there's all kinds
- 29:02Speaker 1: of chemicals in the environment. You hear about this, oh,
- 29:05Speaker 1: there's a whole list of carcinogens. And they put them
- 29:07Speaker 1: on the on the labels on different chemicals. They say
- 29:10Speaker 1: carcinogenic potential and whatever you have.
- 29:13Speaker 2: What are the types of things that are carcinogenic that
- 29:15Speaker 2: most people don't realize?
- 29:17Speaker 1: Oh, well, now we're talking about microplastics. We're talking about.
- 29:21Speaker 2: Is that in part what causes breast cancer? Because I
- 29:24Speaker 2: always think about deodorant with breast cancer and... the stuff
- 29:27Speaker 2: that we're kind of lathering onto our arms.
- 29:29Speaker 1: Yeah, well, the one that was most interesting was the
- 29:32Speaker 1: talcum powder one. How does talcum powder would cause ovarian cancer? Okay,
- 29:37Speaker 1: it's taken up into the urogenital tract. and it forms
- 29:40Speaker 1: a foci in a part of the ovarian tissue.
- 29:43Speaker 2: What's a foci?
- 29:44Speaker 1: A locus, like a collection of material. A foci is
- 29:50Speaker 1: an area where, say, talcum materials would be accumulating. And
- 29:55Speaker 1: that leads to an inflammatory... area of the body. And
- 30:01Speaker 1: our immune system comes in to see what's going on.
- 30:04Speaker 1: Our immune system is a healing machine. And they see
- 30:07Speaker 1: something that's not normal. Normally, they would clean it up.
- 30:10Speaker 1: But they throw cytokines and growth factors on there, leading
- 30:14Speaker 1: to dysregulated damage to mitochondria and dysregulated. And then you
- 30:17Speaker 1: get this tumor that starts.
- 30:19Speaker 2: So if I get a talcum powder granule or whatever,
- 30:23Speaker 2: and it goes into my body, my body then tries
- 30:25Speaker 2: to attack it to sort it out. And in doing so,
- 30:29Speaker 2: it creates inflammation, which leads to.
- 30:31Speaker 1: Damage to mitochondria in a particular group of cells near
- 30:33Speaker 1: that foci.
- 30:34Speaker 2: Okay. And this is applicable to, I guess, a lot
- 30:36Speaker 2: of different nanoparticles.
- 30:38Speaker 1: Yeah. And microplastics are this now. They're looking at this.
- 30:41Speaker 1: But then we have chemical carcinogens, tetrahydrochloride. There's all kinds
- 30:44Speaker 1: of other things that can actually damage arsenics and these
- 30:48Speaker 1: kinds of chemicals, urethane, anything that could chronically damage a mitochondrion, forcing...
- 30:56Speaker 1: over time, forcing it to upregulate the fermentation, the energy
- 31:00Speaker 1: without oxygen.
- 31:01Speaker 2: Isn't this most things? I'm trying to figure out how
- 31:04Speaker 2: to live my life.
- 31:05Speaker 1: Yeah, well, that's why it was called the oncogenic paradox.
- 31:08Speaker 1: But you can avoid that. That's why I'm saying, if
- 31:11Speaker 1: you can keep your mitochondria healthy, exercise and reduce consumption
- 31:18Speaker 1: of highly processed carbohydrates.
- 31:19Speaker 2: Do I need to be avoiding these microplastics as well?
- 31:21Speaker 1: You know, the problem with microplastics, they're very ubiquitous. We're
- 31:25Speaker 1: not really sure We're just now becoming aware of it.
- 31:28Speaker 1: Nobody really knew that before. Look it up. But it
- 31:33Speaker 1: could cause small foci in different populations of cells. But,
- 31:37Speaker 1: you know, it's very hard to really chronically damage mitochondria.
- 31:41Speaker 1: Mitochondria are a tough organelle. The problem is we chronically
- 31:44Speaker 1: abuse it without realizing what we need to do to
- 31:47Speaker 1: keep it healthy. So even if you are exposed to
- 31:50Speaker 1: chemical carcinogens, even if you are exposed to all these things,
- 31:53Speaker 1: but you're keeping your body as healthy as you possibly can,
- 31:56Speaker 1: you could possibly delay or even prevent the damage to
- 32:00Speaker 1: the mitochondria, even though you are being exposed to this.
- 32:04Speaker 1: So it's actually in your hands. You can actually reduce
- 32:09Speaker 1: risk for cancer by knowing what keeps your mitochondria healthy.
- 32:14Speaker 1: Vigorous exercise, fasting, water-only fasting. You know, it's very hard.
- 32:20Speaker 1: Sometimes when we were putting mice on calorie restriction, it
- 32:23Speaker 1: was hard to get them to get tumors. Their body
- 32:26Speaker 1: was so healthy. This was shown years ago by a
- 32:29Speaker 1: couple of scientists in mice, using mice that developed a
- 32:32Speaker 1: lot of breast cancer. If you put them on a
- 32:35Speaker 1: calorie-restricted diet, the incidence was way, way down. So cancer
- 32:38Speaker 1: is very preventable. It's a very preventable disorder. It's just
- 32:42Speaker 1: that we're doing everything we possibly can to induce it
- 32:46Speaker 1: in our diet lifestyle.
- 32:48Speaker 2: A lot of big institutions believe that cancer is a
- 32:50Speaker 2: genetic problem. you believe otherwise?
- 32:57Speaker 1: The evidence is striking. I mean, it's not whether you believe,
- 33:01Speaker 1: it's what the data tell us. Okay. So according to
- 33:04Speaker 1: the somatic mutation theory of cancer, mutations in the nucleus
- 33:08Speaker 1: lead to dysregulated cell growth. That's the somatic mutation theory.
- 33:12Speaker 1: In the mitochondrial metabolic theory, it's a transition from oxidative
- 33:15Speaker 1: phosphorylation to a fermentation metabolism inside the cell. The mutations
- 33:22Speaker 1: are Largely irrelevant. What do you mean by that? When
- 33:26Speaker 1: the mitochondria become defective, they throw out ROS, reactive oxygen species,
- 33:33Speaker 1: that are carcinogenic and mutagenic. Whoa, what does that mean?
- 33:36Speaker 1: Causing mutations. So a lot of the mutations that we
- 33:39Speaker 1: see in the nucleus of the tumor cell that is
- 33:42Speaker 1: the subject of the somatic mutation theory are downstream effects
- 33:46Speaker 1: of the dysfunction of the mitochondria. So the mitochondria is
- 33:49Speaker 1: causing a downstream effect, which are mutations, which, according to
- 33:52Speaker 1: the somatic mutation theory, are the cause of the dysregulated
- 33:55Speaker 1: cell growth. Let me tell you why that's absolutely untrue.
- 33:59Speaker 1: There's some cancer cells growing out of control that have
- 34:01Speaker 1: no mutations and normally not discussable. How can that be?
- 34:04Speaker 1: That's a challenge to the theory. If the theory says
- 34:07Speaker 1: that all cancers have mutations and you have some cancers
- 34:10Speaker 1: that have no mutations and they're growing out of control,
- 34:13Speaker 1: that should say, oh, bell ring one. Then the somatic
- 34:17Speaker 1: mutation people, people who think this, said, oh, okay, we
- 34:21Speaker 1: have a problem here. Not all mutations are the ones
- 34:24Speaker 1: that cause the dysregulated, only some. And we have a
- 34:27Speaker 1: name for those some. That's called driver mutation. Okay, now
- 34:30Speaker 1: it's a nice term. Because some of those mutations are
- 34:32Speaker 1: called passengers. They don't really do anything. But the drivers
- 34:35Speaker 1: are the ones that lead to the dysregulated cell growth.
- 34:38Speaker 1: So we should be focusing our attention on these driver mutations.
- 34:41Speaker 1: New evidence from the recent scientific literature, can you believe this?
- 34:45Speaker 1: They're taking tissue, normal tissues from patients, different organs and
- 34:49Speaker 1: things like this, from not patients, from normal people, no cancer,
- 34:52Speaker 1: perfectly like yourself here. We would take tissue from you
- 34:55Speaker 1: and say, oh my Christ, look at that. You got
- 34:56Speaker 1: driver mutations in your esophagus and your different parts of
- 35:00Speaker 1: your body. You got driver, but you don't have a tumor.
- 35:02Speaker 1: What's going on with that? How do you explain that
- 35:04Speaker 1: these driver mutations are causing dysregulated cell growth when we
- 35:07Speaker 1: have thousands of driver mutations that are there that are
- 35:11Speaker 1: not causing dysregulated cell growth? Oh, okay. That's another problem.
- 35:16Speaker 1: The biggest devastating information against the somatic mutation theory is
- 35:20Speaker 1: if you take the nucleus from a tumor cell, cleanly
- 35:22Speaker 1: take it out of the tumor cell, and you have
- 35:25Speaker 1: another normal cell here, you take the nucleus out of
- 35:28Speaker 1: the normal cell and you put the tumor cell into
- 35:30Speaker 1: that cytoplasm, you get regulated growth, no dysregulated growth. But
- 35:34Speaker 1: if I have the normal cell and have a tumor cell,
- 35:37Speaker 1: take the tumor nucleus out of there and take the
- 35:39Speaker 1: normal nucleus and put it into the tumor cytoplasm, which
- 35:42Speaker 1: contains defective mitochondria, dysregulated cell growth. This has been seen
- 35:47Speaker 1: over and over and over again.
- 35:48Speaker 2: So just to summarize that, so if you take the
- 35:50Speaker 2: tumor nucleus out of the cell and put it into
- 35:52Speaker 2: a normal healthy cell, everything's fine.
- 35:56Speaker 1: Everything is fine.
- 35:57Speaker 2: But if you take healthy cell nucleus and put it
- 35:59Speaker 2: into a tumor cell, you still have the.
- 36:01Speaker 1: Same- Dysregulated cell growth.
- 36:02Speaker 2: Tumor growth, which means that it's not the nucleus.
- 36:05Speaker 1: Absolutely.
- 36:06Speaker 2: It's something else.
- 36:06Speaker 1: It's something else. And that's the mitochondria. And I told you,
- 36:09Speaker 1: then you have cancer cells with no mutations. And then
- 36:11Speaker 1: you have driver mutations in normal cells that never become cancer.
- 36:14Speaker 1: You put all those things together. And you have to
- 36:18Speaker 1: be a hopeless ideologue to think that cancer is a
- 36:23Speaker 1: genetic disease. It's a silent assumption in the field that
- 36:27Speaker 1: cancer is a genetic... Every textbook of biology, cell biology,
- 36:30Speaker 1: and bio... Cancer is a genetic disease.
- 36:32Speaker 2: Why hasn't people's opinions changed despite the evidence that you present?
- 36:38Speaker 1: It's a very difficult thing. It goes back to when
- 36:42Speaker 1: you have one theory replacing another theory. It's called paradigm shifts.
- 36:48Speaker 1: And all in history of science, paradigm shifts have been
- 36:51Speaker 1: met with great, great resistance. The clearest one was the
- 36:56Speaker 1: Copernican Revolution when for 1,800 years, astronomers in our society
- 37:06Speaker 1: early astronomers thought the Earth was immovable in the center
- 37:09Speaker 1: of the solar system. For 1,000, this was Claudius Ptolemy, Aristotle,
- 37:14Speaker 1: and the Bible, and all these Earth is immovable, and
- 37:18Speaker 1: the sun and the moon and the planets all revolve
- 37:20Speaker 1: around the Earth. 1,800 years. Even Copernicus was working with
- 37:25Speaker 1: these mathematical formulations. Koepp was being constantly confused until he said,
- 37:31Speaker 1: what happens if we put the sun in the center
- 37:34Speaker 1: of the solar system and consider the Earth as simply
- 37:36Speaker 1: another planet that would revolve. All of a sudden, things
- 37:39Speaker 1: started to make sense. And Giordano Bruno, a theologian, was
- 37:45Speaker 1: put to death for suggesting that Copernicus was right. There
- 37:50Speaker 1: was a tremendous resistance on the part of the Roman
- 37:53Speaker 1: Catholic Church at that time. And this is the same
- 37:55Speaker 1: thing that happened when Louis Pasteur said that germs, rather
- 38:01Speaker 1: than bad air, are the cause of disease. So and
- 38:04Speaker 1: when Darwin Wallace theory of evolution came, it's not special creation.
- 38:08Speaker 1: It's natural selection that can explain this. These were massive
- 38:12Speaker 1: paradigm changes in the history of science. And what we're
- 38:16Speaker 1: seeing today is the same thing. The mitochondria is the
- 38:19Speaker 1: center of the problem with cancer, not the nucleus. The mitochondria,
- 38:23Speaker 1: it's a mitochondrial metabolic disease. And once you realize that,
- 38:27Speaker 1: we're going to drop these death rates massively in a
- 38:29Speaker 1: very number of years for sure.
- 38:32Speaker 2: So if we take two paths, and if we realize
- 38:34Speaker 2: that the mitochondria is the center of the dysfunction and
- 38:38Speaker 2: ultimately disease in the cell, if we go down that path,
- 38:42Speaker 2: what impact do you think that will have on the
- 38:43Speaker 2: cancer statistics over the coming years?
- 38:46Speaker 1: It'll drop it massively. I'm not going to say we'll
- 38:49Speaker 1: get rid of cancer completely. But here's the thing. We
- 38:53Speaker 1: may never get rid of it, but we can learn
- 38:55Speaker 1: to live with it and keep it at bay. If
- 38:57Speaker 1: we know that it can't survive without these two fuels
- 39:00Speaker 1: and you can do a diet and lifestyle that can
- 39:03Speaker 1: restrict the availability of those two fuels and keep your
- 39:05Speaker 1: mitochondria as healthy as you possibly can.
- 39:08Speaker 2: What if we don't go down that path? What do
- 39:09Speaker 2: you think?
- 39:10Speaker 1: Then you're going to be right. One out of two
- 39:11Speaker 1: people are going to be having cancer. Your statistics are
- 39:14Speaker 1: going to be absolutely correct.
- 39:17Speaker 2: Is there anybody that you believe? Because, you know, when
- 39:19Speaker 2: we talk about these subjects, often we think of like
- 39:21Speaker 2: Big Pharma and the incentives and money and follow the
- 39:24Speaker 2: money and you'll figure out why people don't want change.
- 39:26Speaker 2: Is any of that sort of conspiratorial thinking correct in
- 39:30Speaker 2: your view?
- 39:31Speaker 1: I don't know if that's conspiracy. I don't like conspiracy terms.
- 39:34Speaker 1: That's absurd. I like what are the facts of what
- 39:38Speaker 1: we're looking at.
- 39:39Speaker 2: But do you see a resistance from Big Pharma to
- 39:42Speaker 2: entertain this point of view?
- 39:44Speaker 1: What do you think? What do you think? I mean,
- 39:47Speaker 1: do you think this is, I mean, you're making a
- 39:48Speaker 1: lot of, not you, but But people in those industries,
- 39:51Speaker 1: the hospital industry is making enormous amounts of money. They're
- 39:55Speaker 1: awarding– we get $ 7 billion a year for cancer research
- 39:59Speaker 1: in the National Cancer Institute, awarding many, many– not all,
- 40:03Speaker 1: many grants to looking for gene mutations and all this
- 40:06Speaker 1: kind of stuff. And we have drugs that are extremely
- 40:10Speaker 1: expensive based on a somatic mutation theory of cancer that
- 40:13Speaker 1: are basically not dropping the death rate. As I said,
- 40:16Speaker 1: while we're talking here, we're going to have 140 people dead.
- 40:20Speaker 1: from cancer. 1,700 people a year is getting worse and worse.
- 40:24Speaker 1: As you said, we're always running for raising money for
- 40:27Speaker 1: cancer research. Where's all that money going? What are you
- 40:30Speaker 1: doing with all that money? No accountability. And then when
- 40:32Speaker 1: you look at the scientific advisory committee of all these
- 40:35Speaker 1: societies that you're running for, they all think publish papers
- 40:38Speaker 1: on cancer as a genetic disease. It's too hard for
- 40:42Speaker 1: the field to accept at this point. It's too traumatic.
- 40:48Speaker 1: at what I'm saying. It's too disruptive to a massive
- 40:52Speaker 1: industry at this time. They will come to gradually adjust
- 40:57Speaker 1: to what I'm saying. It's just a matter of time
- 40:58Speaker 1: because we cannot continue this trajectory. It's immoral what we're
- 41:03Speaker 1: doing to some of these people.
- 41:04Speaker 2: I read a stat that said the global incidence of
- 41:06Speaker 2: early onset cancer increased by roughly 80% between 1990 and 2019.
- 41:10Speaker 2: That's in the BMJ oncology.
- 41:11Speaker 1: Mm-hmm.
- 41:16Speaker 2: Early onset of cancer is basically patients under the age
- 41:18Speaker 2: of 50. And when I think about this, you know,
- 41:20Speaker 2: growing up in the UK, whenever there's a fun run,
- 41:23Speaker 2: a charity race, a marathon, whatever it might be, cancer
- 41:26Speaker 2: research gets the money. And to hear that, you know,
- 41:29Speaker 2: there's been so much money invested in cancer research over
- 41:31Speaker 2: the last couple of decades, but there's been an increase
- 41:34Speaker 2: of 80% in early onset cancer in the same period.
- 41:38Speaker 2: For me, I'm like, This research doesn't appear to be
- 41:42Speaker 2: being very effective.
- 41:43Speaker 1: Well, as I said, what people don't do is they
- 41:46Speaker 1: never ask, where does the research go? What kind of research?
- 41:49Speaker 1: What are you doing? What is the research? It's the
- 41:51Speaker 1: theory that drives the impetus to do research.
- 41:55Speaker 2: Now, a lot of great stuff has been done on
- 41:58Speaker 2: keeping people alive that suffer from cancers, right? Because if
- 42:01Speaker 2: you think about the probability of dying from a cancer,
- 42:04Speaker 2: I'm assuming that has gone down.
- 42:07Speaker 1: Yeah, to some extent it has. There's two ways of
- 42:10Speaker 1: looking at it. It's called progression-free survival and overall survival.
- 42:14Speaker 1: These are the terminologies that are used in the clinical
- 42:17Speaker 1: world of cancer. And they represent the approval of drugs
- 42:20Speaker 1: through the Food and Drug Administration. If you have a
- 42:23Speaker 1: drug that improves progression-free survival, progression-free means it looks like
- 42:30Speaker 1: the drug is working on the tumor. Because the tumor,
- 42:34Speaker 1: you can see it. It gets bigger and bigger and
- 42:36Speaker 1: more lethal and more lethal. And if I see it
- 42:38Speaker 1: not growing nearly as much, I say, wow, look at that.
- 42:43Speaker 1: It's slowing what we call traditional progression. It's called progression-free survival.
- 42:48Speaker 1: And then you have overall survival. So you have two
- 42:52Speaker 1: ways to approve drugs mostly for cancer, right? How does
- 42:56Speaker 1: it work on progression-free survival? And how does it work
- 42:59Speaker 1: on overall survival? Well, they stop looking at overall survival.
- 43:02Speaker 1: Now somebody's going to bark and say, well, you know,
- 43:05Speaker 1: bottom line is mostly progression-free, which means that the patients,
- 43:08Speaker 1: it looks like the tumor is being effectively managed, but
- 43:11Speaker 1: they live only a couple of months longer than they
- 43:14Speaker 1: would have if they didn't use this drug. So therefore,
- 43:17Speaker 1: it's approved. And that, as opposed to overall survival, you know,
- 43:22Speaker 1: you're only living a two, okay, you've lived two and
- 43:24Speaker 1: a half extra months. The tumor looked like it was
- 43:27Speaker 1: managed pretty well, but your overall survival is this much
- 43:30Speaker 1: but you didn't see the tumor growing, we're going to
- 43:33Speaker 1: approve that drug. So a lot of the new drugs
- 43:36Speaker 1: that we're giving do a really good job at progression-free survival,
- 43:39Speaker 1: but they do a horrible job in keeping people alive
- 43:41Speaker 1: much longer, which ultimately is what you want to do.
- 43:44Speaker 1: You want overall survival. Let me give you an example, Avastin, Bevacizumab.
- 43:49Speaker 1: This is an immoral drug that should never be used
- 43:51Speaker 1: on people. It was blocked because it caused colon perforations
- 43:55Speaker 1: in women with breast cancer. They still use it on
- 43:57Speaker 1: brain cancer. And so in the tumor, you've got a tumor.
- 44:01Speaker 1: You can see it with PET imaging. Not so much
- 44:05Speaker 1: MRI and CAT scan. You can see it there. And
- 44:07Speaker 1: it's looking there. Okay. You can see it. Now you
- 44:11Speaker 1: give the patient Avastin, which is this anti-angiogenic drug. It's
- 44:17Speaker 1: supposed to stop the abnormal blood vessels, right? They think
- 44:20Speaker 1: that the angiogenesis blood vessels is driving the dysregulated growth.
- 44:25Speaker 1: It's the fermentation that's driving the dysregulated growth, by the way.
- 44:29Speaker 1: So all of a sudden, the tumor kind of disappears.
- 44:32Speaker 1: It doesn't look like it. Whoa, patient gets all excited.
- 44:35Speaker 1: The physician looks and says, look at that. Look at that.
- 44:38Speaker 1: Looks like you're doing well. What the drug does is
- 44:41Speaker 1: it causes the tumors to permeate your entire brain, like
- 44:47Speaker 1: spreading it through your whole brain. You don't live any longer.
- 44:51Speaker 1: But you had this progression free. Look at the tumor.
- 44:54Speaker 1: So the patient gets excited because it looks like the
- 44:56Speaker 1: tumor is disappearing with this very expensive drug. But what
- 45:00Speaker 1: it does is it almost guarantees that that patient will
- 45:02Speaker 1: not survive because you spread the tumor cells through the
- 45:04Speaker 1: whole brain. So this is why I call it an
- 45:07Speaker 1: immoral kind of a thing.
- 45:09Speaker 2: But chemotherapy and sort of these radiation therapies, they have
- 45:13Speaker 2: proven to keep people alive who otherwise would have died.
- 45:16Speaker 1: In some cases, it can. And that's another thing we
- 45:20Speaker 1: have to look at. I work heavily in brain tumors
- 45:23Speaker 1: and glioblastomas and things like that. When you irradiate somebody's brain,
- 45:27Speaker 1: who has one of these tumors, you free up massive
- 45:29Speaker 1: amounts of glucose and glutamine in the microenvironment. And if
- 45:32Speaker 1: you look at the survival, when we did survival, looked
- 45:35Speaker 1: at survival curves for glioblastoma throughout the world, you can't
- 45:38Speaker 1: even design experiments so consistent how fast people will die.
- 45:41Speaker 1: It's like all the different hospitals have the same survival,
- 45:45Speaker 1: same survival. What are you doing? Well, we do chemo.
- 45:47Speaker 1: We do surgical debulking, temozolomide, and we give steroids, which
- 45:52Speaker 1: raise blood sugar, and we irradiate. We irradiate. We irradiate.
- 45:55Speaker 1: Everybody's dead. So not everybody, but five-year survival is very,
- 46:01Speaker 1: very low. Ten-year survival is almost zero.
- 46:04Speaker 2: But if you got a breast cancer or if you got.
- 46:07Speaker 1: … This is brain cancer I'm talking about. Brain cancer, right.
- 46:09Speaker 1: This is freeing up. Now, yes, if you have a
- 46:11Speaker 1: circumscribed tumor and it's not anywhere else, you can come
- 46:15Speaker 1: in with a radiation or surgical procedure and essentially cure
- 46:18Speaker 1: that patient. But if you have any level of spread
- 46:21Speaker 1: or anything like this, that person now … Also, if
- 46:26Speaker 1: you're taking a toxic poison into your body, like red devil, doxorubicin,
- 46:31Speaker 1: they call it red devil. Your pee turns red, everything
- 46:33Speaker 1: turns red.
- 46:34Speaker 2: What is that? Is that chemotherapy?
- 46:35Speaker 1: Yes, it's a chemotherapy to kill a small group of
- 46:37Speaker 1: cells or maybe a little bit of a spread. But
- 46:42Speaker 1: your hair falls out, your body gets brutalized by this.
- 46:46Speaker 1: And then if you survive the cancer, and many people do,
- 46:48Speaker 1: we have millions and millions of cancer survivors on this planet.
- 46:52Speaker 1: But many, many folks in that group suffer from the
- 46:55Speaker 1: adverse effects of being poisoned or irradiated or surgically mutilated.
- 46:59Speaker 1: I mean, they have to change their hold. And oftentimes
- 47:02Speaker 1: the cancer comes back or they die from cardiovascular disease
- 47:05Speaker 1: or they die from secondary adverse effects of being brutalized
- 47:10Speaker 1: with medieval, I call it medieval, approaches to this. Are
- 47:13Speaker 1: you kidding me what they're doing to cancer patients? So
- 47:17Speaker 1: when we do metabolic therapy, we shrink the tumor down
- 47:21Speaker 1: for sure. Then the surgeon can come in And he
- 47:24Speaker 1: sees it's smaller, fewer blood vessels because of the metabolic therapy.
- 47:27Speaker 1: And we can take out a greater amount of this.
- 47:30Speaker 1: And then we transition back to prevent this tumor from recurring.
- 47:34Speaker 1: Metabolic therapy can be used to not only prevent the cancer,
- 47:38Speaker 1: but can also be used to treat the cancer. Most hospitals,
- 47:43Speaker 1: most people say, well, I really want to do things
- 47:45Speaker 1: to prevent cancer. Can I do standard of care before
- 47:48Speaker 1: I have a tumor? What do you mean? You want
- 47:50Speaker 1: to go into a major cancer clinic and have toxarubicin
- 47:55Speaker 1: and radiation to your body just in the event that
- 47:57Speaker 1: you might get a cancer? This is absurd. But yet
- 47:59Speaker 1: when you have cancer, that's what they do to you, right?
- 48:02Speaker 1: But with metabolic therapy, you can use it as both
- 48:04Speaker 1: a prevention and a treatment. It's just that with the treatment,
- 48:07Speaker 1: we bring in some more drugs to target the glutamine.
- 48:08Speaker 1: We don't do that on the prevention side.
- 48:10Speaker 2: On the... I was just looking at some stats as
- 48:12Speaker 2: you were speaking around this five-year survival rates of a
- 48:15Speaker 2: variety of different cancers over time. And... It does appear
- 48:20Speaker 2: that survival rates of these cancers, from breast cancer, prostate cancer,
- 48:24Speaker 2: to lung cancer, to leukemias and various melanomas, has improved
- 48:28Speaker 2: since the 1970s. So the 1970s to the 1990s to 2010s,
- 48:34Speaker 2: there's been an improvement in the survival rate, which I
- 48:37Speaker 2: guess is a credit to the research that's been done.
- 48:40Speaker 2: What you're saying is that the treatments we have still
- 48:43Speaker 2: today are horrific.
- 48:45Speaker 1: Yeah, and the survivals are not that much greater. It's
- 48:48Speaker 1: not like you're getting massively longer survivals.
- 48:51Speaker 2: Yeah, I mean, and I have to preface that these
- 48:53Speaker 2: stats might not be right because this is AI we're
- 48:55Speaker 2: dealing with here. But there's a 5%, for example, with
- 48:58Speaker 2: breast cancer between the 1990s and 2010, there's just a
- 49:01Speaker 2: 5% difference.
- 49:03Speaker 1: In overall survival?
- 49:04Speaker 2: In overall survival.
- 49:04Speaker 1: Okay, so your survival, your overall survival is two and
- 49:07Speaker 1: a half to three months greater.
- 49:08Speaker 2: I don't actually have those stats.
- 49:11Speaker 1: No, but that's the evidence, the papers that we're looking at.
- 49:15Speaker 2: So how do we prevent this then? I'm 32 years
- 49:20Speaker 2: old now. So I want to make sure that I
- 49:23Speaker 2: live my life in such a way that I limit
- 49:24Speaker 2: my chance of cancer. One of the things I always
- 49:26Speaker 2: reflect on is the fact that many of the people
- 49:28Speaker 2: that I know that have got cancer, breast cancer or
- 49:30Speaker 2: other forms of cancer, appear to be remarkably healthy.
- 49:33Speaker 1: Yeah, always at the beginning. Not always, but many times
- 49:38Speaker 1: the person comes in and says, geez, I just was
- 49:39Speaker 1: diagnosed with cancer. I didn't know I had it. I
- 49:41Speaker 1: didn't feel bad. And then all of a sudden you
- 49:43Speaker 1: get treated and they look like death warmed over.
- 49:45Speaker 2: But I'm saying like how can healthy people be getting
- 49:48Speaker 2: cancer if there's this sort of central … Well, because
- 49:50Speaker 2: as I.
- 49:51Speaker 1: Said, and we're seeing this. I'm seeing it in my own.
- 49:55Speaker 1: I'm getting more and more emails from young people in
- 49:58Speaker 1: their 30s, late 20s, 30s, early 40s, like with colon cancer,
- 50:02Speaker 1: breast cancer and all these kinds of things. But look
- 50:04Speaker 1: at our diet and lifestyle situation today. Those things that
- 50:08Speaker 1: I'm talking about, lack of exercise, a lot of stress,
- 50:10Speaker 1: poor sleep, bad food, all of this kind of stuff
- 50:13Speaker 1: impacting parts of our bodies.
- 50:16Speaker 2: So what do we do about it, though?
- 50:18Speaker 1: Know about it.
- 50:19Speaker 2: And then what do we do? So I know now.
- 50:21Speaker 1: That's personal choice. I'm not here to take pieces and
- 50:23Speaker 1: jelly donuts off the market, for sure, or breakfast cereal.
- 50:26Speaker 1: I love that stuff, too. But the question is, I
- 50:29Speaker 1: don't eat it every day. And I know if I do,
- 50:31Speaker 1: it'll kill me. so so yeah skipping meals water only
- 50:39Speaker 1: fat occasionally there's a lot of things you can do
- 50:41Speaker 1: to keep your mitochondria healthy.
- 50:43Speaker 2: Okay so tell me what those things are i just.
- 50:45Speaker 1: Exercise you look like you're a pretty healthy guy yeah
- 50:47Speaker 1: i go to the gym you don't look morbidly obese
- 50:49Speaker 1: to me not yet not yet well that's important because
- 50:52Speaker 1: you don't ever want.
- 50:53Speaker 2: It yet we won't be in america too long so much.
- 50:55Speaker 1: Yeah well and listen it's not just the united states
- 50:57Speaker 1: we were kind of like the first ones to plow
- 50:59Speaker 1: that field But it's starting to spread everywhere. I think
- 51:01Speaker 1: in China, they have the most 200 million obese people
- 51:04Speaker 1: in China now.
- 51:05Speaker 2: So should I be on a keto diet then?
- 51:07Speaker 1: Here's what we did. Okay. We developed the glucose ketone
- 51:11Speaker 1: index calculator at Boston College. All right. My students and I,
- 51:14Speaker 1: because we were trying to work with cancer patients, blood
- 51:18Speaker 1: sugar and ketones independently of each other. And we had
- 51:23Speaker 1: a ketone meter and we had a blood glucose meter.
- 51:25Speaker 1: So we were monitoring ketones by itself. and glucose by itself.
- 51:30Speaker 1: And we worked with a very nice woman from America
- 51:34Speaker 1: who lived in Nice, France, who since passed away from
- 51:36Speaker 1: a brain stem tumor. It was very, very difficult. We
- 51:38Speaker 1: kept her alive very long, but eventually we didn't know
- 51:41Speaker 1: what we know now. But she got into an argument
- 51:45Speaker 1: for a handicapped parking spot with her neighbor upstairs and
- 51:49Speaker 1: her blood sugar went through the roof. She ran upstairs
- 51:51Speaker 1: and she took her blood sugar and And she says,
- 51:54Speaker 1: oh my God, the tumor is going to grow. I said,
- 51:55Speaker 1: what's your ketones? And she says, oh, it's still two
- 51:57Speaker 1: and a half millimolar. Well, that's still pretty high. Usually
- 52:00Speaker 1: it's very, very low. It's very high. So my students
- 52:04Speaker 1: and I, we said, you know, this is too traumatic
- 52:06Speaker 1: to try to measure these two independently. Why don't we
- 52:09Speaker 1: make a singular number, divide the glucose in millimolar in
- 52:12Speaker 1: the blood by the ketone in millimolar in the blood.
- 52:15Speaker 1: Now you get this number that's much more stable. And
- 52:18Speaker 1: it allows the cancer patient to know that if I
- 52:21Speaker 1: keep this zone at 2.0 and below, my tumor cells
- 52:24Speaker 1: aren't going to be able to grow very fast. I
- 52:26Speaker 1: did this for the brain cancer, right? Now it's being
- 52:28Speaker 1: used for all cancers. And now it's being used for
- 52:31Speaker 1: guys like yourself who just want to stay healthy. Because
- 52:34Speaker 1: what it is essentially is a quantitative determination if you're
- 52:37Speaker 1: in the paleolithic zone or not. Oh, so if I'm
- 52:40Speaker 1: at 2.0, like my friend Dominic D'Agostino, he's always down
- 52:44Speaker 1: in these zones. He's a paleolithic man living in modern society.
- 52:48Speaker 2: What's a Paleolithic man?
- 52:49Speaker 1: That's how our ancestors were during the Paleolithic period.
- 52:53Speaker 2: Okay, so he's got the right balance of glucose and ketones.
- 52:55Speaker 1: Like we did when we were hunting mammoths and buffaloes
- 52:59Speaker 1: and these kinds of things. When we were hunter-gatherers and
- 53:02Speaker 1: the thousands of years of our existence as a species,
- 53:05Speaker 1: tens of thousands of years, he is in that zone.
- 53:08Speaker 2: Is he in keto?
- 53:09Speaker 1: Yeah, well, that's what the low GKI is. That means
- 53:13Speaker 1: you're at a level of keto. Yes, he doesn't eat
- 53:16Speaker 1: a lot of carbohydrates in his diet. So it's leafy
- 53:18Speaker 1: vegetables and a lot of meat and this kind of thing.
- 53:21Speaker 1: Sparingly on fruits, like grapefruits, we learn from the epilepsy field,
- 53:26Speaker 1: grapefruits provide a tremendous amount of vitamin C and do
- 53:29Speaker 1: not spike glucose. That's very interesting. So you can have
- 53:33Speaker 1: certain fruits that can keep you in this metabolic zone.
- 53:37Speaker 1: I call it the paleolithic zone, which is the way
- 53:39Speaker 1: we evolved when there was no cancer. in our, in
- 53:41Speaker 1: our existence.
- 53:42Speaker 2: When people hear that, they might start jumping on the
- 53:43Speaker 2: paleo diet. I don't even know what the paleo diet is.
- 53:45Speaker 1: Not a paleo diet. It's, it's diets that are low
- 53:47Speaker 1: in carbohydrates. Okay.
- 53:49Speaker 2: Okay.
- 53:50Speaker 1: Um, Mediterranean diets. Like people say to me, what should
- 53:53Speaker 1: I eat? Should I eat this and that? Normally you
- 53:55Speaker 1: would eat foods that have very low, low glycemic index,
- 53:59Speaker 1: which means the speed with which glucose is released like
- 54:01Speaker 1: a banana, very high in glycemic index. You eat a banana,
- 54:05Speaker 1: your blood sugar immediately spikes. Many fruits are like that. Um,
- 54:09Speaker 1: But you want foods that keep a low steady GKI. Now,
- 54:14Speaker 1: I built that calculator for brain cancer patients initially. Then
- 54:20Speaker 1: we realized it's powerful for all cancers. We put the
- 54:23Speaker 1: cancer patient in the low glucose ketone index. We get
- 54:27Speaker 1: them down in there. Then we come in with the
- 54:28Speaker 1: glutamine targeting drugs to kind of polish off these tumors
- 54:31Speaker 1: or put them in even a more dormant state. But
- 54:34Speaker 1: now we're finding all these young kids, like yourself, all
- 54:36Speaker 1: these 30, 20-year-olds with the GKI. I mean, they're out
- 54:40Speaker 1: to weightlifting and they're looking at their G. They don't
- 54:41Speaker 1: have cancer. They're just excited to see if they can
- 54:44Speaker 1: get into this paleolithic zone by themselves. And yes, that
- 54:47Speaker 1: will prevent cancer because you can't get cancer if you're
- 54:50Speaker 1: mitochondrial healthy. If you're in a paleolithic zone where our
- 54:53Speaker 1: ancestors rarely have ever got cancer, then you're back in this, oh,
- 54:56Speaker 1: you mean to tell me I can't eat this and
- 54:58Speaker 1: I can't eat that? What does it do to your GKI? Oh,
- 55:00Speaker 1: it makes it go up. Well, don't eat that.
- 55:03Speaker 2: So you did a study on dogs, a dog with
- 55:05Speaker 2: a tumor. Yes. Can you tell me about that study?
- 55:08Speaker 1: It was a woman came to me. And this is
- 55:11Speaker 1: what I say. You don't have to have a PhD
- 55:14Speaker 1: in biochemistry to understand some of the things. This woman
- 55:18Speaker 1: had no degree whatsoever. She just heard about what we
- 55:22Speaker 1: did to these mice. And she did the same thing
- 55:25Speaker 1: to her dog. It was a pit bull. And at
- 55:28Speaker 1: age seven years old, it had a big mast cell
- 55:30Speaker 1: tumor on its lip. So she listened to my YouTube
- 55:33Speaker 1: video over and over. She said to me, I just
- 55:35Speaker 1: kept listening. She says, I got some raw chicken. She
- 55:41Speaker 1: says dogs, wolves evolved to eat chickens. So she got
- 55:44Speaker 1: some chicken, chopped up the chicken. She cut the calories.
- 55:48Speaker 1: She found some dog food calculator to how much calories
- 55:51Speaker 1: the dog was getting. She cut the calories. The dog
- 55:54Speaker 1: lost only 5% of its body weight. She got fish oil,
- 55:59Speaker 1: raw eggs. And cut all the calories. Everything was all
- 56:03Speaker 1: natural for this dog. And all of a sudden, we
- 56:06Speaker 1: have the pictures. You can see them if you saw
- 56:08Speaker 1: the picture. Big tumor on its lip. The veterinarian said,
- 56:13Speaker 1: this dog is going to survive. You have to give
- 56:15Speaker 1: him chemo and radiation and surgery and all this kind
- 56:17Speaker 1: of stuff. And it's going to cost a lot of money.
- 56:19Speaker 1: The dog's going to have diarrhea. She didn't want any
- 56:21Speaker 1: part of that. So she said, well, let's just try
- 56:24Speaker 1: this metabolic thing. And she's kept all the records and
- 56:28Speaker 1: the pictures and what she did and how much she
- 56:30Speaker 1: gave the dog and all this. So I was able
- 56:31Speaker 1: to get all that information from her, put my friend
- 56:35Speaker 1: Lauren Nations, who is a veterinarian, on the paper because
- 56:40Speaker 1: I said, what, biology guy at Boston College is telling
- 56:42Speaker 1: you how to manage cancer in a dog. We got
- 56:44Speaker 1: to have some veterinarian on here to validate to make
- 56:47Speaker 1: sure he's there. And he looked at the pictures and
- 56:49Speaker 1: we looked at all the things. It disappeared. So what happened?
- 56:52Speaker 1: was the dog eventually died of heart disease at 15
- 56:55Speaker 1: and a half years of age. So essentially, that's the only,
- 56:59Speaker 1: when people say, well, metabolic therapy cure cancer, I say
- 57:03Speaker 1: metabolic therapy is never considered a cure for cancer. It's
- 57:07Speaker 1: an effective non-toxic management for cancer. But in the case
- 57:10Speaker 1: of that dog, it appeared to work, it's a cure
- 57:12Speaker 1: for the dog. But that's the only one I'll say, oh,
- 57:14Speaker 1: he's going to say a cure cannot. That dog happened
- 57:16Speaker 1: to get, he died from old age from a heart attack.
- 57:19Speaker 1: And we did it with a brain tumor guy, Pablo Kelly,
- 57:21Speaker 1: who just passed away, unfortunately, from a surgical. He had
- 57:26Speaker 1: a major cerebral hemorrhage after his surgery from Devon, England.
- 57:31Speaker 1: You know Devon, England?
- 57:32Speaker 2: That's where I'm from.
- 57:32Speaker 1: Are you from Devon?
- 57:33Speaker 2: Yeah.
- 57:34Speaker 1: Oh, wow. Well, Pablo was there. He just passed away, fortunately.
- 57:36Speaker 1: We were talking to him the day before he passed away.
- 57:39Speaker 2: Pablo.
- 57:39Speaker 1: Pablo Kelly. So he was from Devon, England, had a glioblastoma,
- 57:44Speaker 1: which is the worst of the worst. They said, and
- 57:47Speaker 1: he's all over your newspapers there in Devon. He was
- 57:49Speaker 1: always sending me articles from England. Man rejects standard of care.
- 57:55Speaker 1: So he had this glioblastoma and they took the tissue out.
- 57:59Speaker 2: Which is brain cancer.
- 58:00Speaker 1: Yeah, brain, the worst of the brain cancers. They took
- 58:03Speaker 1: the tumor out and they said, oh, it's inoperable, inoperable.
- 58:09Speaker 1: But if you do radiation and chemo, you might live nine,
- 58:14Speaker 1: maybe 12 months at the most. Well, Pablo came from
- 58:17Speaker 1: a family of like, we don't dabble in this kind
- 58:20Speaker 1: of medicine. We're more holistic kind of people. So he
- 58:23Speaker 1: emailed me, this was in 2014, and said, I want
- 58:27Speaker 1: to try this metabolic thing. So he rejected chemo and radiation.
- 58:34Speaker 1: And they said it wasn't surgically capable of being completely
- 58:37Speaker 1: removed anyway. So he did this I gave him the
- 58:41Speaker 1: information that I give to everybody. And this was way
- 58:44Speaker 1: back before we knew a lot of what we now know.
- 58:47Speaker 1: And I said, this poor guy, he doesn't want. And
- 58:50Speaker 1: they said, you're going to be dead. They browbeat him.
- 58:52Speaker 1: They try to force him to put that radiation mask on.
- 58:55Speaker 1: They hacked his beard off, all this kind of stuff.
- 58:58Speaker 1: And he just jumped up. He said, I can't do
- 58:59Speaker 1: this stuff. So he didn't take any steroids. He didn't
- 59:02Speaker 1: take any radiation. He didn't take any chemo. He just
- 59:06Speaker 1: did the metabolic therapy. And he's on English things with
- 59:09Speaker 1: all of his paleo diet, which is actually a very
- 59:12Speaker 1: low-carbohydrate diet. He had the avocados there. He had the
- 59:15Speaker 1: fish oil there. He had this different stuff. Two or
- 59:18Speaker 1: three years go by. He emails me. I said, geez, Pablo,
- 59:22Speaker 1: I thought you would have been dead. You're still alive?
- 59:24Speaker 1: What's going on with that? So he calls me up
- 59:29Speaker 1: and he says, you know, I went in for a
- 59:31Speaker 1: CAT scan. The doctors are like still surprised that he's alive.
- 59:35Speaker 1: And they said, this tumor is still there and it's growing.
- 59:39Speaker 1: And they think they can cut it out now. So
- 59:41Speaker 1: he was three years on just metabolic approach. He didn't
- 59:45Speaker 1: take any glutamine inhibitors, which was really remarkable. So anyway,
- 59:49Speaker 1: he asked me, and I have physician friends that are
- 59:53Speaker 1: radiologists that can look at it. We measured it when
- 59:55Speaker 1: it was first First diagnosed in 2014. And then we
- 59:59Speaker 1: saw it did become a little bigger. And now the
- 1:00:02Speaker 1: surgeon said, I think I can get it. It looks
- 1:00:04Speaker 1: more resectable. Here it was inoperable. Now it becomes resectable.
- 1:00:08Speaker 1: So he took it out. And Pablo recovered really well.
- 1:00:13Speaker 1: And the surgeon says, I think I got it all. Wow.
- 1:00:17Speaker 1: And Pablo is measuring his glucose ketone index with our
- 1:00:21Speaker 1: ketone monitor. So I had every day, sometimes two and three.
- 1:00:24Speaker 1: Five years of data on Pablo Kelly. Can you believe this?
- 1:00:28Speaker 1: So anyway, Pablo thinks he's cured because the surgeon, all
- 1:00:32Speaker 1: of a sudden he goes back to his kind of
- 1:00:34Speaker 1: weak ways. And you can see that his GKI goes up.
- 1:00:38Speaker 1: And all of a sudden the tumor starts to show
- 1:00:40Speaker 1: up again. Puts the fear of God back into him.
- 1:00:43Speaker 1: Goes back on a more restrict condition. Another three years
- 1:00:47Speaker 1: goes by. And this time the tumor is growing slowly,
- 1:00:50Speaker 1: very slowly. Don't forget, glioblastomas kill you very quickly. So
- 1:00:54Speaker 1: with standard of care, you can barely get out of–
- 1:00:56Speaker 1: at his age, if you can get two years, you're
- 1:00:58Speaker 1: doing really good. So anyway, now he's three and he's
- 1:01:01Speaker 1: got six years out. And he says, you know, it's
- 1:01:06Speaker 1: still back. I got to go in. So this is
- 1:01:09Speaker 1: second debulking. First debulking goes off, gets back on. Another
- 1:01:12Speaker 1: second debulking. Another three years goes by, he has a
- 1:01:15Speaker 1: third debulking. Can you believe this?
- 1:01:16Speaker 2: What's a debulking?
- 1:01:17Speaker 1: A debulking is the cutting the tumor out. It's the
- 1:01:20Speaker 1: surgical removal of this tumor. But he's never had radiation
- 1:01:24Speaker 1: or chemo or any of the kinds of what we
- 1:01:25Speaker 1: call standards of care. And now he has– I talked
- 1:01:32Speaker 1: to him a couple of weeks ago and he was
- 1:01:35Speaker 1: doing really, really good. He had the third removal and
- 1:01:39Speaker 1: we were laughing with myself and Dr. Duryea and my associates.
- 1:01:44Speaker 1: He says, yeah, can you imagine? I've had now three
- 1:01:48Speaker 1: operations on a previously inoperable tumor. What? So we were saying, wow,
- 1:01:55Speaker 1: they got that one wrong. Didn't they, Pablo? And they
- 1:01:57Speaker 1: kept wanting to irradiate him and do all this stuff.
- 1:01:59Speaker 1: And he said, no, no, I'm going to keep doing this.
- 1:02:01Speaker 1: And so we were speaking to him. And he's now
- 1:02:05Speaker 1: 10 years. The tumor was diagnosed in August 2014. And
- 1:02:11Speaker 1: he passed away August 2024. They tried to go in
- 1:02:16Speaker 1: and get the last bit of tumor out of his brain.
- 1:02:18Speaker 1: We got him We talked to him. Thumbs up, smiling,
- 1:02:23Speaker 1: talking like crazy. Six hours later, cerebral hemorrhage and he dies.
- 1:02:26Speaker 1: So he didn't die from the cancer. He died from
- 1:02:29Speaker 1: a surgical problem with the surgery. So he was– you
- 1:02:33Speaker 1: talk about long-term survivors. You rarely survive cancer. two years
- 1:02:38Speaker 1: with a glioblastoma, the fact that he was out 10 years.
- 1:02:41Speaker 1: And if he hadn't had that last bit of surgery,
- 1:02:43Speaker 1: the guy would have still been alive because he was
- 1:02:45Speaker 1: talking like you and I are talking. This is a
- 1:02:46Speaker 1: guy who has a terminal. So I said to Pablo,
- 1:02:50Speaker 1: I said, you could outlive me. I said, we're all
- 1:02:53Speaker 1: terminal to some extent, right? We're never, all of us
- 1:02:55Speaker 1: aren't going to live to that. I said, he was
- 1:02:57Speaker 1: a young guy. He was only 22 or 23 when
- 1:02:59Speaker 1: he was diagnosed. He was in his 30s now when
- 1:03:01Speaker 1: he passed away, 10 years. So he's 33, 34 years old.
- 1:03:06Speaker 1: And I said, you know, I could be dead before you.
- 1:03:08Speaker 1: And we were laughing. We had a good time. And
- 1:03:10Speaker 1: the next thing I know, I get an email from
- 1:03:11Speaker 1: his wife. He said, Pablo is brain dead or something.
- 1:03:17Speaker 1: I said, what the hell happened? What happened to this
- 1:03:20Speaker 1: poor guy? And it wasn't the cancer. So I don't
- 1:03:24Speaker 1: know how long he would have lived, how many more things.
- 1:03:27Speaker 1: But what I'm saying, oh, he's an anecdote. Well, listen,
- 1:03:30Speaker 1: if I had a drug that did what metabolic therapy
- 1:03:33Speaker 1: did and I could get more people like Pablo, are
- 1:03:35Speaker 1: you kidding me? they'd be running all over the world.
- 1:03:38Speaker 2: And when you say metabolic therapy, you mean the combination
- 1:03:41Speaker 2: of the calorie restrictive ketogenic approach?
- 1:03:44Speaker 1: Yes.
- 1:03:45Speaker 2: Yeah.
- 1:03:45Speaker 1: Avoiding. Well, first of all, you're avoiding, you're avoiding things
- 1:03:47Speaker 1: that are going to kill you. The radiation is going
- 1:03:49Speaker 1: to kill you for the, for many people, not all people. Okay.
- 1:03:52Speaker 1: Everybody said, well, listen, you can, you can look at the,
- 1:03:54Speaker 1: go have people look at the data themselves for crying
- 1:03:56Speaker 1: out loud and you can see how long you're going
- 1:03:58Speaker 1: to live. He didn't do what they, what they grab
- 1:04:00Speaker 1: everybody in.
- 1:04:01Speaker 2: What did he do specifically?
- 1:04:02Speaker 1: He didn't take radiation or chemo and he, brought his
- 1:04:05Speaker 1: glucose ketone index down to the 2.0 zone and kept
- 1:04:09Speaker 1: it low. And he took some supplements and a few
- 1:04:12Speaker 1: things here and there, but he wasn't really targeting the
- 1:04:15Speaker 1: glutamine like we found now certain parasite medications will be
- 1:04:20Speaker 1: effective in targeting glutamine. So we're doing all non-toxic strategies
- 1:04:24Speaker 1: to manage cancer. You don't have to be brutalized by
- 1:04:27Speaker 1: the system if you know what to do and how
- 1:04:29Speaker 1: to do it. The problem is most of the poor
- 1:04:31Speaker 1: oncologists never heard of what I'm talking about. The stuff
- 1:04:33Speaker 1: I'm telling you right now, they never heard of it.
- 1:04:35Speaker 2: The risk is someone gets cancer that's listening to this
- 1:04:37Speaker 2: or someone has cancer that's listening to this. I mean, statistically,
- 1:04:40Speaker 2: there's a lot of people listening to this that have
- 1:04:41Speaker 2: cancer right now. And they're speaking to their doctor. And
- 1:04:44Speaker 2: their doctor is saying, chemotherapy, radiation therapy, et cetera.
- 1:04:48Speaker 1: Et cetera. And glucose has nothing to do with the tumor.
- 1:04:50Speaker 1: Eat whatever you want.
- 1:04:52Speaker 2: Yeah. And so what do you say to those people
- 1:04:54Speaker 2: who they've just got a diagnosis and their doctors are saying, right, listen,
- 1:04:59Speaker 2: this is pretty severe. We're going to suggest that you
- 1:05:01Speaker 2: take chemotherapy.
- 1:05:02Speaker 1: Yeah.
- 1:05:03Speaker 2: You're not telling them not to take chemotherapy, are you?
- 1:05:05Speaker 1: I'm not telling them that. And what we found is
- 1:05:08Speaker 1: that when you are in nutritional ketosis with a glucose
- 1:05:12Speaker 1: ketone index of 2.0 or below, my colleagues that we
- 1:05:16Speaker 1: work with in Istanbul, Turkey, were able to show that
- 1:05:18Speaker 1: chemotherapies at much lower dosages can be even more therapeutically
- 1:05:22Speaker 1: powerful when you're in nutritional ketosis. So you don't have
- 1:05:26Speaker 1: to get rid of a lot of these different procedures
- 1:05:28Speaker 1: that we have today. I'm just saying radiation for brain cancer.
- 1:05:31Speaker 1: I'm not saying radiation for lung or some of the
- 1:05:33Speaker 1: other cancers. Because if you can shrink those tumors down
- 1:05:37Speaker 1: and make them very weak and vulnerable, a surgical procedure,
- 1:05:40Speaker 1: a radiation procedure, even low-dose chemo could come in. And
- 1:05:44Speaker 1: even immunotherapy, if you took a big tumor and shrunk
- 1:05:47Speaker 1: it down to a small nub and it's resistant to
- 1:05:50Speaker 1: a lot of the things, they all have to share
- 1:05:53Speaker 1: something in common for them to survive this path. that
- 1:05:57Speaker 1: might be an immunotherapy could come in because they're gonna
- 1:06:00Speaker 1: target whatever all of them have together and you could
- 1:06:02Speaker 1: possibly get rid of it that way.
- 1:06:04Speaker 2: I'm thinking of a friend of mine that has been
- 1:06:06Speaker 2: diagnosed with brain cancer, brain tumor. And this is one
- 1:06:10Speaker 2: of the most, you know, it's a woman in her
- 1:06:13Speaker 2: 40s or 50s, trying to keep her anonymous as possible,
- 1:06:17Speaker 2: who is just the most fit athletic person that I know,
- 1:06:22Speaker 2: eats amazingly well, is literally known for exercise. And I'd go, how?
- 1:06:28Speaker 2: How is it possible that someone who I would probably
- 1:06:30Speaker 2: say is fitter than I am, if you looked at
- 1:06:32Speaker 2: their sort of metabolic health, has got a severe brain tumor?
- 1:06:36Speaker 1: Well, they can stay healthy for, and I'm not saying
- 1:06:41Speaker 1: everybody who has, and it depends on what kind of
- 1:06:43Speaker 1: a tumor it is as well. Is it a glioblastoma, oligodendroglioma,
- 1:06:47Speaker 1: you know, peanut, there's a lot of different kinds of tumors.
- 1:06:50Speaker 2: Well, I know that it's not growing necessarily, but it's
- 1:06:53Speaker 2: big and it's in the brain and they're going to
- 1:06:55Speaker 2: remove it for a surgical operation.
- 1:06:57Speaker 1: Well, if they can, what we always suggest for the
- 1:06:59Speaker 1: brain cancer, if you do metabolic therapy up front, and
- 1:07:02Speaker 1: I've had surgeons tell me this, you can shrink it
- 1:07:05Speaker 1: down because one of the, it's angry, it's an angry thing, right?
- 1:07:10Speaker 1: And you can see some slight invasion. If you can
- 1:07:13Speaker 1: shrink that down so that it's more circumscribed, now the
- 1:07:17Speaker 1: surgeon can look at it and go, oh my God.
- 1:07:19Speaker 1: We know many, many scientific publications, the more you can debulk,
- 1:07:23Speaker 1: that's called the removal of the tumor, debulking, the longer
- 1:07:27Speaker 1: the patient will survive. The evidence is massive to support that. But,
- 1:07:30Speaker 1: you know, with a lot of these brain tumors, you
- 1:07:32Speaker 1: don't get it all. And there's always some little piece
- 1:07:34Speaker 1: that remains. And when you irradiate, you explode the ability
- 1:07:37Speaker 1: of the cells to ferment energy and it's very hard
- 1:07:40Speaker 1: to kill them. But if you can get the majority
- 1:07:43Speaker 1: of it out and then transition the patient back into
- 1:07:46Speaker 1: a metabolic state, keeping the pressure on those tumor cells,
- 1:07:49Speaker 1: you can remain healthy like Pablo. I mean, these guys can.
- 1:07:52Speaker 2: And when you found in mice is that when ketogenic
- 1:07:54Speaker 2: diet was combined with a hyperbaric oxygen therapy, the average
- 1:07:57Speaker 2: survival time was increased by roughly 80%.
- 1:08:00Speaker 1: Yeah, even more sometimes now. But okay, so why do
- 1:08:04Speaker 1: we do hyperbaric oxygen, right? That's the question. What's going
- 1:08:08Speaker 1: on with hyperbaric oxygen? Why is this like a good thing?
- 1:08:13Speaker 1: It works best when the patient and the mouse is
- 1:08:15Speaker 1: in nutritional ketosis. Okay, so look, we have a tumor.
- 1:08:20Speaker 1: We irradiate that tumor. How does the radiation kill the
- 1:08:23Speaker 1: tumor cells? It hits oxygen, blows up, and it causes
- 1:08:26Speaker 1: a reactive ROS, and it's like stepping on a landmine.
- 1:08:31Speaker 1: It blows the tumor up, right? So cancer cells protect themselves,
- 1:08:36Speaker 1: even though they make a lot of rust. They're this
- 1:08:39Speaker 1: close to death anyway. But they have a very powerful
- 1:08:43Speaker 1: antioxidant system. And interestingly enough, That besides causing the dysregulated growth,
- 1:08:50Speaker 1: the glucose and the glutamine also protect them to some
- 1:08:53Speaker 1: extent from the ROS that they're making. Can you believe this?
- 1:08:56Speaker 2: The ROS.
- 1:08:57Speaker 1: ROS. ROS. Reactive oxygen. species that are carcinogenic and mutagenic.
- 1:09:03Speaker 1: So they destroy our proteins, lipids, and nucleic acids. They're
- 1:09:09Speaker 1: disruptive molecules. So radiation will cause a ROS in the microenvironment, ROS,
- 1:09:15Speaker 1: that'll blow up and kill cells, normal and tumor cells.
- 1:09:19Speaker 1: But if you want to selectively kill tumor cells with ROS,
- 1:09:23Speaker 1: not to cause your hair to fall out, your gums
- 1:09:26Speaker 1: to bleed, and all this crazy stuff, you take the patient,
- 1:09:29Speaker 1: you put him in nutritional ketosis, and you say he's
- 1:09:32Speaker 1: got low GKI. Then you go into hyperbaric oxygen, which
- 1:09:35Speaker 1: dissolves oxygen directly into your blood now. It's better than
- 1:09:38Speaker 1: just breathing 100% oxygen because you can actually dissolve oxygen
- 1:09:41Speaker 1: in the bloodstream. then you're taking away the two fuels
- 1:09:46Speaker 1: that protect the tumor and you're giving it internal ROS,
- 1:09:49Speaker 1: which kills the tumor internally, only to the tumor cell,
- 1:09:52Speaker 1: not to your surrounding tissues. So you're killing, selectively killing
- 1:09:56Speaker 1: tumor cells without collateral damage to the rest of your body.
- 1:09:59Speaker 1: As a matter of fact, the rest of your cells
- 1:10:01Speaker 1: are getting super healthy because they're burning ketones and pure oxygen. Unbelievable.
- 1:10:05Speaker 2: How do we measure for.
- 1:10:06Speaker 1: Can you believe this? I can't even believe I'm saying
- 1:10:08Speaker 1: this stuff myself.
- 1:10:09Speaker 2: Yeah.
- 1:10:11Speaker 1: You really got to know the biochemistry. And you have
- 1:10:13Speaker 1: to know the physiology of your own body. And you
- 1:10:15Speaker 1: have to understand evolutionary biology.
- 1:10:17Speaker 2: Most people just aren't that intelligent, including me.
- 1:10:20Speaker 1: It's not intelligence.
- 1:10:22Speaker 2: Most people kind of want things, sort of simple principles
- 1:10:27Speaker 2: that they can live by.
- 1:10:28Speaker 1: And also quick and easy.
- 1:10:30Speaker 2: Yeah, of course.
- 1:10:30Speaker 1: Okay. They don't want to do what I'm talking about it.
- 1:10:33Speaker 1: Because it might be, oh, the other thing, let me
- 1:10:35Speaker 1: tell you one thing and remember it. If you do
- 1:10:37Speaker 1: metabolic therapy, success rides heavily on your shoulders. You're not
- 1:10:41Speaker 1: sitting there like some manikin, some guy's poisoning and irradiating you.
- 1:10:45Speaker 1: To make metabolic therapy work, you are the one doing
- 1:10:48Speaker 1: the GKI. You're the one, it's your soul. You're responsible
- 1:10:53Speaker 1: for your existence on this planet. You're going to put
- 1:10:55Speaker 1: your precious soul in the hands of someone who has
- 1:10:59Speaker 1: less of a knowledge about the problem than you might.
- 1:11:03Speaker 2: As an entrepreneur, I'm always looking for ways to connect
- 1:11:06Speaker 2: and to create. And that's why I decided to launch
- 1:11:08Speaker 2: the Conversation Cards. I turned to Shopify, who also sponsored
- 1:11:11Speaker 2: this podcast, and Shopify made it so easy to set
- 1:11:15Speaker 2: up an online store and reach all of you, no
- 1:11:17Speaker 2: matter where you are in the world. I remember the
- 1:11:20Speaker 2: challenges we faced when we first launched the Diary of
- 1:11:22Speaker 2: a CEO conversation cards, managing inventory, ensuring a seamless checkout process,
- 1:11:26Speaker 2: and reaching our audience. Shopify stepped in and made everything
- 1:11:29Speaker 2: so straightforward and efficient. It was like having an entire
- 1:11:32Speaker 2: team of experts by our side, allowing us to focus
- 1:11:35Speaker 2: on creating content and connecting with you. What I love
- 1:11:38Speaker 2: about Shopify is no matter how big you intend to
- 1:11:40Speaker 2: grow your business, they give you everything you need to
- 1:11:43Speaker 2: take control and take your business to the next level.
- 1:11:46Speaker 2: And to say thank you for listening to this podcast,
- 1:11:48Speaker 2: we're giving you a trial, which is just $ 1 a month,
- 1:11:50Speaker 2: and you can sign up by going to shopify.com slash Bartlett.
- 1:11:54Speaker 2: The link is in the description below. Could you be
- 1:11:57Speaker 2: predisposed genetically to cancer?
- 1:11:59Speaker 1: Yeah, that's where those germline mutations, but you can manage that.
- 1:12:02Speaker 2: Because people think, you know, my grandmother had breast cancer,
- 1:12:05Speaker 2: my mother had breast cancer. So, you know.
- 1:12:07Speaker 1: They live in a common environment too. It's not like you're, like,
- 1:12:10Speaker 1: you know, to prove that you and all the siblings
- 1:12:12Speaker 1: would have to be raised in a different environment, different countries,
- 1:12:16Speaker 1: different lifestyles. And then see if you all got cancer
- 1:12:18Speaker 1: at the same time under all these different conditions, that's
- 1:12:20Speaker 1: definitely genetic. That's like Huntington's disease, Tay-Sachs disease or these
- 1:12:24Speaker 1: kinds of things. where they'll manifest regardless of the environment.
- 1:12:27Speaker 2: So are you saying to me that I should, as
- 1:12:29Speaker 2: a 32-year-old man that's cancer-free, God willing, I think, touch wood,
- 1:12:34Speaker 2: I should calorie restrict myself to keep my mitochondria healthy
- 1:12:38Speaker 2: and my metabolism healthy now? I should be in a
- 1:12:44Speaker 2: sort of calorie restricted state?
- 1:12:45Speaker 1: I say it's good to visit the state. Our Paleolithic
- 1:12:48Speaker 1: ancestors had no choice. There wasn't a donut shop on
- 1:12:52Speaker 1: every corner. There wasn't pizzas. There weren't the kinds of
- 1:12:55Speaker 1: highly processed carbohydrate foods available to them.
- 1:12:58Speaker 2: So should I be fasting? Should I be doing keto?
- 1:13:00Speaker 1: You know, I don't want to tell you what you
- 1:13:02Speaker 1: should or should not do. I'm not a physician here.
- 1:13:04Speaker 1: I'm a scientist. I study what causes these things and
- 1:13:07Speaker 1: I study how to manage them. You have to read
- 1:13:09Speaker 1: what I'm saying and you have to come to your
- 1:13:12Speaker 1: own decisions about how you want to conduct your life.
- 1:13:15Speaker 1: I've given you information.
- 1:13:16Speaker 2: What's your view on fasting?
- 1:13:18Speaker 1: Fasting is a powerful way to get your body into
- 1:13:21Speaker 1: nutritional ketosis, but it ain't easy. Try doing it. You
- 1:13:25Speaker 1: try doing it. See how easy it is. It ain't easy, right?
- 1:13:29Speaker 1: But that's why we developed this procedure where if you go,
- 1:13:33Speaker 1: rather than going cold turkey and say, well, today I'm
- 1:13:36Speaker 1: going to have a big, I'm going to eat as
- 1:13:37Speaker 1: much as I can, and then tomorrow, okay, you can
- 1:13:39Speaker 1: go tomorrow. It's the second, third days when you start
- 1:13:42Speaker 1: to really know what the hell is going on. Believe me,
- 1:13:44Speaker 1: I've tried it. It ain't easy. That's why we developed it.
- 1:13:48Speaker 1: a zero-carb diet for 14 days, 10 to 14 days,
- 1:13:51Speaker 1: just zero. You eat meat, fish, chicken, whatever you want,
- 1:13:54Speaker 1: but just don't eat any bread, pasta, this kind of thing.
- 1:13:57Speaker 2: On keto, how do we get into that sort of
- 1:14:00Speaker 2: ketosis state that people often talk about?
- 1:14:02Speaker 1: Measure your glucose ketone index. How do I do that?
- 1:14:05Speaker 1: With the Keto Mojo meter. You can buy it from Amazon. Okay. Okay,
- 1:14:09Speaker 1: you can buy it. Now, don't forget they get a
- 1:14:11Speaker 1: free Libra meter now for the blood. They're working on
- 1:14:13Speaker 1: ketone blood meters, but it's not there yet. Right now,
- 1:14:16Speaker 1: the Keto-Mojo or some other Keto meters where you can
- 1:14:20Speaker 1: prick your finger like a diabetic. You take a glucose
- 1:14:22Speaker 1: strip and you put it on the blood and you
- 1:14:24Speaker 1: put it into the machine. It tells you what your
- 1:14:25Speaker 1: glucose is. Squeeze your finger a little bit more. Take
- 1:14:28Speaker 1: the ketone strip, touch it to the blood, put it
- 1:14:30Speaker 1: in the meter. It gives you the ketone value. Push
- 1:14:33Speaker 1: the button. GKI comes right up. Okay. Okay. Very simple.
- 1:14:37Speaker 1: Everybody can buy it from Amazon. Get the meter. Buy
- 1:14:40Speaker 1: the consumables. And then they can test it. This is
- 1:14:43Speaker 1: what Pablo, this is what all the cancer patients, the
- 1:14:45Speaker 1: ones who really want to get into metabolic ketosis.
- 1:14:48Speaker 2: I think I've tried keto before. And I say think
- 1:14:50Speaker 2: because I didn't measure my keto levels. I was assuming
- 1:14:53Speaker 2: I did.
- 1:14:53Speaker 1: Yeah. No, it's really people say, well, I haven't eaten.
- 1:14:56Speaker 1: I'm in keto. How do you know? Well, I blew
- 1:14:58Speaker 1: into this thing and the bulb came on. I peed
- 1:14:59Speaker 1: on a strip. It looked like it was ketosis. They
- 1:15:02Speaker 1: are indirect measures. The most accurate is the blood measure.
- 1:15:05Speaker 2: It's hard to stay in that state. For most people, right?
- 1:15:09Speaker 2: This is one of the things I hear.
- 1:15:10Speaker 1: Because the temptations in our society are so strong. Yeah.
- 1:15:14Speaker 1: I mean, Paleolithic man had no choice. Do you think
- 1:15:16Speaker 1: he– that was his state. That's all he knew for
- 1:15:19Speaker 1: thousands and thousands, tens of thousands, hundreds of thousands of years.
- 1:15:23Speaker 1: That's all he knew. He didn't say, oh, let me
- 1:15:25Speaker 1: go down to get a big jelly-filled donut down at
- 1:15:28Speaker 1: the end of the river there. No, there's none of that.
- 1:15:30Speaker 1: He had to live in that state. Now we have
- 1:15:33Speaker 1: so many temptations. All the things that we are biologically
- 1:15:36Speaker 1: clear for. When you see obesity, that's evolution in action.
- 1:15:41Speaker 1: They are the descendants of our long ancestors that could
- 1:15:45Speaker 1: hold on to energy so efficiently. We were an energy-starved
- 1:15:49Speaker 1: species for the majority of our existence on the planet.
- 1:15:52Speaker 1: So anything we ate would be very little waste. We
- 1:15:55Speaker 1: never pee out glucose. Glucose is converted to fat, and
- 1:15:57Speaker 1: we store energy as fat. So those guys are energy-efficient
- 1:16:02Speaker 1: human beings. Now, all of a sudden, we find ourselves
- 1:16:05Speaker 1: with everything. And boom! That's evolution in action, man. You're
- 1:16:10Speaker 1: allowing to see how we can store energy so efficiently
- 1:16:15Speaker 1: because our ancestors lived through such environmental forcing. We had famines.
- 1:16:21Speaker 1: We had long treks. Our body could store energy so
- 1:16:25Speaker 1: efficiently because it wasn't We had to store what little
- 1:16:28Speaker 1: we could get from the environment.
- 1:16:29Speaker 2: Now we've got 300 million Americans in this food environment
- 1:16:32Speaker 2: where when they walk out their front door, they see
- 1:16:35Speaker 2: it's a Dunkin' Donut. They can lie in bed and
- 1:16:37Speaker 2: order a Dunkin' Donut during 10 minutes.
- 1:16:39Speaker 1: You don't even have to un-ass the car. They can't
- 1:16:41Speaker 1: get through the window. No energy expenditure, energy in.
- 1:16:46Speaker 2: So giving them this information might be fairly futile because-
- 1:16:50Speaker 2: The temptation?
- 1:16:51Speaker 1: I'm not here to tell people, again, I'm not here
- 1:16:53Speaker 1: to tell people what they should or should not do.
- 1:16:55Speaker 1: I'm just here to explain, like, why do we have
- 1:16:57Speaker 1: all this? It's not mystery. It's all biological evolution. You
- 1:17:00Speaker 1: understand biological evolution. Almost everything that I'm talking about makes
- 1:17:04Speaker 1: perfect sense. And unfortunately, that's not part of our scientific
- 1:17:09Speaker 1: literacy anymore.
- 1:17:10Speaker 2: So we need what, discipline?
- 1:17:12Speaker 1: Discipline is important. Discipline is important. You know, every major religion,
- 1:17:18Speaker 1: had a point of fasting to be, whether you're Islamic, Judaism,
- 1:17:26Speaker 1: or whatever, Catholicism, Hinduism, whatever. They always had some sort
- 1:17:31Speaker 1: of fasting. Why do you do fasting? Because you want
- 1:17:34Speaker 1: to purify your body. You want to become closer to God.
- 1:17:36Speaker 1: You want to feel in control. And if you do
- 1:17:37Speaker 1: it with prayer, it's even better. So There was a
- 1:17:45Speaker 1: reason for doing all that. And people realized the ancients
- 1:17:49Speaker 1: knew this kind of thing. But we don't do that anymore.
- 1:17:53Speaker 1: We don't go 40 days without food like Jesus did
- 1:17:56Speaker 1: in the deserts. But a human being, you could absolutely
- 1:18:00Speaker 1: do that. I know because I can look at your weight,
- 1:18:03Speaker 1: I can look at your size, and I can pretty
- 1:18:04Speaker 1: much tell you how long you can go with before
- 1:18:06Speaker 1: you died. And how do I know that? Because George Cahill,
- 1:18:10Speaker 1: a good friend, late George Cahill, ran the Joslin Diabetes
- 1:18:13Speaker 1: Center And he evaluated people that would just order only
- 1:18:17Speaker 1: fasting until death and some of those constant prison camps
- 1:18:25Speaker 1: and things. So he was able to know how long
- 1:18:29Speaker 1: you could go. Now, what about Angus Barberi went 377
- 1:18:34Speaker 1: days without food. George Cahill would fast some of these
- 1:18:38Speaker 1: obese people for 250, 300 days. What happens inside their body?
- 1:18:42Speaker 1: They're burning fat. So what happens is you burn fat. Okay,
- 1:18:46Speaker 1: liver stores a lot of, bones store the minerals You
- 1:18:50Speaker 1: can get minerals from your bones. You can get a
- 1:18:52Speaker 1: lot of fat storage. Vitamins are stored in fat, a
- 1:18:56Speaker 1: lot of vitamin D.
- 1:18:57Speaker 2: Outside of the weight loss, what's going on? We said
- 1:19:01Speaker 2: religious people used to fast to get closer to God,
- 1:19:04Speaker 2: which seems to me to point to some sort of
- 1:19:05Speaker 2: cognitive change.
- 1:19:06Speaker 1: Yes, and that's from burning ketones.
- 1:19:08Speaker 2: Okay.
- 1:19:09Speaker 1: When you burn ketones, I said in the brain, when
- 1:19:10Speaker 1: your brain starts shifting to ketones, your energy, the bang
- 1:19:14Speaker 1: for the buck for each calorie that comes in from
- 1:19:16Speaker 1: a ketone body increases the efficiency of oxidative phosphorylation.
- 1:19:20Speaker 2: So you're more focused?
- 1:19:22Speaker 1: Massively. And, you know, this is why our ancestors were
- 1:19:26Speaker 1: the way that if you are dependent on killing some
- 1:19:30Speaker 1: animal for your survival and you are out on the hunt,
- 1:19:35Speaker 1: you are focused. Because if you're not focused, you're going
- 1:19:39Speaker 1: to starve to death. So every sense organ in our
- 1:19:42Speaker 1: body is super jacked when you're in these ketonic states.
- 1:19:48Speaker 1: And these guys walking around with headphones, you know, all this.
- 1:19:51Speaker 1: I mean, this is like depriving ourselves of the natural
- 1:19:54Speaker 1: ways of our ancestry. Don't forget, you and I are
- 1:19:58Speaker 1: not just here over the last, you know, 100, 300,
- 1:20:00Speaker 1: 400 years. We are the descendants of members that are
- 1:20:05Speaker 1: same as us, you know, hundreds of thousands of years ago.
- 1:20:08Speaker 1: They just didn't have the technology that we have today.
- 1:20:12Speaker 1: But if you could bring a Paleolithic man from, say, 500,000
- 1:20:15Speaker 1: years ago, and you gave him a bunch of donuts
- 1:20:17Speaker 1: and told him, oh, he went to heaven. You mean
- 1:20:19Speaker 1: to tell me I don't have to go out and
- 1:20:20Speaker 1: kill the elk anymore? They're going to hand me the
- 1:20:22Speaker 1: food right through the window. Of course he's going to
- 1:20:24Speaker 1: do that. You go in the cave and you throw
- 1:20:27Speaker 1: a bunch of jelly-filled donuts into a bunch of cavemen
- 1:20:29Speaker 1: who've been chewing on the half-eaten rat or something. You
- 1:20:34Speaker 1: think they're not going to eat those jelly donuts? They
- 1:20:36Speaker 1: have some chimpanzees live with a family down in Florida.
- 1:20:40Speaker 1: I know there's some YouTube thing. The chimps, they're eating
- 1:20:43Speaker 1: the food with the family. And then they give jelly
- 1:20:45Speaker 1: sandwiches to the chimps. They're banging on the table. You'd
- 1:20:48Speaker 1: think they were going to go crazy. Chimpanzees loving the
- 1:20:50Speaker 1: jelly sandwiches.
- 1:20:51Speaker 2: Do you have kids?
- 1:20:52Speaker 1: Yes.
- 1:20:54Speaker 2: What advice would you give to your children if they're
- 1:20:56Speaker 2: listening to this now? about how to prevent their chance
- 1:21:00Speaker 2: of getting sick from cancer?
- 1:21:01Speaker 1: Well, they probably say, well, dad, how come you don't
- 1:21:03Speaker 1: do a lot of the things? First of all, I'm
- 1:21:05Speaker 1: not telling, I told you, I don't tell anybody what
- 1:21:07Speaker 1: to do or how they do it. I'm just telling
- 1:21:09Speaker 1: you the science behind why things work. Yeah, my children,
- 1:21:15Speaker 1: my two sons, they're all very, very successful. And they said,
- 1:21:21Speaker 1: if we ever got cancer, we would be doing the
- 1:21:24Speaker 1: metabolic therapy if we were to ever get cancer. And
- 1:21:27Speaker 1: I said, just keep exercising and do what you can
- 1:21:30Speaker 1: do the best you can in our environment. I mean,
- 1:21:33Speaker 1: don't get me wrong. I'm eating a jelly donut. I'm
- 1:21:35Speaker 1: drinking beer. I'm drinking whiskey.
- 1:21:38Speaker 2: Why?
- 1:21:38Speaker 1: Because I like it. But I'm not going to be
- 1:21:40Speaker 1: doing it all the time. I'm not going to be saying,
- 1:21:44Speaker 1: I'm going to eat pizza, sure. But I'm not going
- 1:21:46Speaker 1: to be not doing it. I do intermittent fasting. I
- 1:21:50Speaker 1: don't eat for 18, 20 hours at a time. I
- 1:21:53Speaker 1: do a lot of exercise over at the university, the
- 1:21:56Speaker 1: gym and the facilities that we have. Um, but I,
- 1:21:59Speaker 1: but I understand. And then if I were to get cancer,
- 1:22:02Speaker 1: I would have to, um, bite the bullet and do
- 1:22:05Speaker 1: what I'm, would do what I know works as much
- 1:22:07Speaker 1: as it wouldn't be pleasurable, but it would be certainly
- 1:22:09Speaker 1: a better alternative than being irradiated and poisoned. I'm telling
- 1:22:12Speaker 1: you that.
- 1:22:13Speaker 2: If that has brought your conviction to the point that
- 1:22:15Speaker 2: you're so convinced that the real issue is this sort
- 1:22:17Speaker 2: of metabolic dysfunction, um, Why aren't you optimizing your life
- 1:22:23Speaker 2: to be sort of metabolically perfect?
- 1:22:25Speaker 1: Well, because I live in the same society you do.
- 1:22:27Speaker 2: Yeah.
- 1:22:27Speaker 1: Okay. And fortunately, yes, our technology has improved significantly. You know,
- 1:22:35Speaker 1: I'm not a monk. I'm not going to be in
- 1:22:37Speaker 1: some monastery, you know, chanting something. I am a member
- 1:22:42Speaker 1: of the society just as you are. And I enjoy
- 1:22:44Speaker 1: the things that we have to offer us to make
- 1:22:47Speaker 1: our lives a little bit more pleasurable. There's nothing like
- 1:22:49Speaker 1: sitting down over a nice meal and having a discussion
- 1:22:52Speaker 1: with some wine and enjoying it. Enjoy the moment. But
- 1:22:56Speaker 1: not to be locked into that kind of diet and
- 1:22:59Speaker 1: lifestyle all the time puts you at risk.
- 1:23:03Speaker 2: There's an election going on in the United States at
- 1:23:05Speaker 2: the moment, Trump versus Kamala Harris. If you won the
- 1:23:09Speaker 2: election and you became president of the United States and
- 1:23:12Speaker 2: you had to introduce some regulations or some laws around
- 1:23:16Speaker 2: food and all of these kinds of things, what would
- 1:23:18Speaker 2: you do?
- 1:23:19Speaker 1: Well, I think you're talking about a food industry. You're
- 1:23:23Speaker 1: talking about a multidimensional economy. I would not, again, you
- 1:23:30Speaker 1: don't want government to tell you what you should do.
- 1:23:34Speaker 1: You should make the choices, but you have to recognize
- 1:23:37Speaker 1: are there choices and what are these choices? Right now,
- 1:23:40Speaker 1: we're not seeing or understanding how things harm people. If
- 1:23:47Speaker 1: we have an obesity epidemic and that would put you
- 1:23:49Speaker 1: at risk for all these horrific chronic diseases, why do
- 1:23:53Speaker 1: they not know that?
- 1:23:54Speaker 2: We introduced some regulation in the UK regarding smoking, so
- 1:23:57Speaker 2: you can't smoke inside anymore.
- 1:23:59Speaker 1: But you see, your secondhand smoke could impact negatively the
- 1:24:03Speaker 1: person sitting next to you. This obese person's personal choice
- 1:24:08Speaker 1: to be obese is not going to make you obese
- 1:24:11Speaker 1: or sick. So this is a different kind of a situation.
- 1:24:15Speaker 1: That has to come from internal to the person. And
- 1:24:17Speaker 1: they have to be concerned with their own health.
- 1:24:19Speaker 2: What about drugs though? Like cocaine is not legal. So
- 1:24:22Speaker 2: why can't they intervene to say you can't have Dunkin' Donuts?
- 1:24:26Speaker 2: Because they're both going to harm the individual.
- 1:24:30Speaker 1: I think you'd get a revolution if you can't eat
- 1:24:32Speaker 1: a Dunkin' Donut. You're not going to get a revolution
- 1:24:34Speaker 1: if you can't have cocaine. You try to go down
- 1:24:38Speaker 1: here in Brooklyn and take away all these donuts from people.
- 1:24:41Speaker 1: You're going to see they're going to go. You know,
- 1:24:44Speaker 1: it's like, it's personal choices. I mean, I like Dunkin' Donuts.
- 1:24:47Speaker 1: I mean, I like the coffee especially. But you can
- 1:24:51Speaker 1: go to a donut shop and get some of these
- 1:24:53Speaker 1: crullers and jelly fills and honey dipped. Are you kidding me?
- 1:24:56Speaker 1: These things are delicious. You ever get these blueberry muffins?
- 1:24:58Speaker 1: You tremble when you eat some of this stuff. You know,
- 1:25:01Speaker 1: and I'm not going to take that away from me.
- 1:25:02Speaker 1: But if I want one, I'm not going to be, oh,
- 1:25:04Speaker 1: every day I got to eat. No, I just don't
- 1:25:06Speaker 1: eat it. On the weekend, I might get one. And
- 1:25:09Speaker 1: even sometimes two or three weeks, months go by before
- 1:25:11Speaker 1: I'll get one. But when you get it, man, you
- 1:25:15Speaker 1: enjoy it. You really love it.
- 1:25:17Speaker 2: Are you hopeful?
- 1:25:18Speaker 1: I am very hopeful. Because when the science comes, you
- 1:25:22Speaker 1: can't suppress the truth. It's going to come out. The evidence,
- 1:25:26Speaker 1: the scientific evidence is there. I'm documenting this scientific. And
- 1:25:30Speaker 1: it's based on the shoulders of Otto Warburg. Are you
- 1:25:32Speaker 1: kidding me? I mean, this was a giant in the
- 1:25:34Speaker 1: field of biochemistry. It's not like I made this stuff up.
- 1:25:37Speaker 1: I'm just extending what he has done to a new dimension.
- 1:25:40Speaker 1: and putting it into a practical application, which he had
- 1:25:43Speaker 1: never done. So it's just an extension of the knowledge
- 1:25:47Speaker 1: base over this time.
- 1:25:48Speaker 2: Why do you care so much?
- 1:25:50Speaker 1: Why do I care so much? You know, I'm not
- 1:25:53Speaker 1: in it for the money. You know what I'm in
- 1:25:55Speaker 1: it for? I want to see the scientific principles substantiated.
- 1:26:02Speaker 1: If you know that you can keep these people alive
- 1:26:05Speaker 1: at a higher quality of life based on the knowledge
- 1:26:07Speaker 1: of the science that's doing that, that's gratification, man. It's
- 1:26:11Speaker 1: gratification to know that these– because you were right on
- 1:26:16Speaker 1: understanding the mechanism of the problem. And if you say–
- 1:26:20Speaker 1: if we do it the way– we're writing a big
- 1:26:22Speaker 1: treatment protocol as we speak. It's under review, a really
- 1:26:25Speaker 1: comprehensive treatment protocol. And we institute that in the clinic.
- 1:26:28Speaker 1: And for glioblastoma patients and these advanced cancers, they're not
- 1:26:32Speaker 1: living a few extra months. They're living several years longer. Why?
- 1:26:36Speaker 1: Because you knew the science. What's wrong with that? That's– gratification.
- 1:26:42Speaker 1: You don't have to make a billion dollars on that.
- 1:26:44Speaker 1: All you have to know is that all those folks
- 1:26:46Speaker 1: are living longer because you understood the science that was
- 1:26:48Speaker 1: put into practical application. Our research is supported by philanthropy
- 1:26:54Speaker 1: and private foundations. That money allows me to do these experiments,
- 1:27:00Speaker 1: to test what I'm testing on preclinical models, and then
- 1:27:03Speaker 1: we translate it back into the clinic directly. And we see,
- 1:27:06Speaker 1: like Pablo Kelly, he should have been done. He should
- 1:27:08Speaker 1: have been done Years and years ago. He lived all
- 1:27:11Speaker 1: those years extra. He's had a wife and he's got kids.
- 1:27:14Speaker 1: He didn't have to have his sperm frozen. He didn't
- 1:27:16Speaker 1: have to have any of that stuff done. What's wrong
- 1:27:18Speaker 1: with that? I'm seeing people that should have been dead
- 1:27:21Speaker 1: a long time ago and they're still alive. And they're saying,
- 1:27:24Speaker 1: I'm doing fine. I get calls from people. Jeez, I
- 1:27:26Speaker 1: thought that guy would have been a goner. He's still alive.
- 1:27:28Speaker 1: He's doing well. I said, that keeps me going because
- 1:27:32Speaker 1: it tells me that we're on the right path. This
- 1:27:35Speaker 1: is a solvable problem. This cancer This cancer can be
- 1:27:39Speaker 1: dropped significantly. You can take away the fear. People now
- 1:27:43Speaker 1: put it on their shoulders. I know what to do,
- 1:27:45Speaker 1: how to do it. I'm going to follow this. Will
- 1:27:47Speaker 1: it work for everybody? No, but it will help a
- 1:27:49Speaker 1: lot of people, much more than what we have today.
- 1:27:52Speaker 1: But it's paradigm change, massive paradigm change. So they will
- 1:27:57Speaker 1: come to know. It's just a matter of time. I
- 1:27:59Speaker 1: don't know how long it's going to take, but I
- 1:28:00Speaker 1: ain't going anywhere. I'm continuing to do this. I'm going
- 1:28:03Speaker 1: to get better and better results, and we're going to
- 1:28:05Speaker 1: keep pushing. I've published these case reports in the scientific literature.
- 1:28:08Speaker 1: Let the scientific field make their decision on the results
- 1:28:12Speaker 1: from these papers.
- 1:28:13Speaker 2: And if you are to succeed, what happens?
- 1:28:16Speaker 1: People improve. I'm not going to live forever. But I
- 1:28:21Speaker 1: know that what I've done with following Otto Warburg and
- 1:28:24Speaker 1: cleaning up the misconceptions and misunderstanding of why he was
- 1:28:28Speaker 1: stalled when the field ran off chasing genes, we've got
- 1:28:31Speaker 1: to bring the Bring it back on track. It's a
- 1:28:33Speaker 1: metabolic problem with metabolic solutions. So that will help a
- 1:28:37Speaker 1: lot of people. But it's also going to change it.
- 1:28:40Speaker 1: of the way people are thinking about this. But I
- 1:28:43Speaker 1: can tell you, they want to open clinics. I get
- 1:28:45Speaker 1: calls from Asia, Africa, South America. They want to open clinics.
- 1:28:50Speaker 1: People are being brutalized by a system that's not working.
- 1:28:53Speaker 1: Don't forget, besides the terrible physical toxicity, people are going
- 1:28:59Speaker 1: bankrupt Their marriages are falling apart because they can't pay
- 1:29:03Speaker 1: for the expensive drugs on these cancer things. And they
- 1:29:05Speaker 1: die and the bills are passed on to their loved ones.
- 1:29:08Speaker 1: This is immoral stuff.
- 1:29:09Speaker 2: Is there a particular case study that's broken your heart
- 1:29:12Speaker 2: more than any others?
- 1:29:14Speaker 1: Trudy DuPont, who originally let me, we built a glucose
- 1:29:19Speaker 1: ketone index calculator on her. Pablo is still, we're still
- 1:29:23Speaker 1: devastated by Pablo's loss because Pablo was a, A guy
- 1:29:27Speaker 1: that I've known for 10 years worked him through and
- 1:29:30Speaker 1: then all of a sudden he gets a cerebral hemorrhage
- 1:29:32Speaker 1: and dies. He was our poster child for how long
- 1:29:34Speaker 1: you could live with a glioblastoma on metabolic therapy. But
- 1:29:38Speaker 1: he didn't die from the cancer. You have some others
- 1:29:41Speaker 1: that we wish they could have lived a little bit
- 1:29:43Speaker 1: longer with the appropriate help. What I find is that
- 1:29:47Speaker 1: sometimes within the family, there's a lot of– the guy,
- 1:29:51Speaker 1: he says, I really want to do what you're doing.
- 1:29:53Speaker 1: But my wife and kids say I'm foolish to do that.
- 1:29:55Speaker 1: So it's still a very– we're in a very early
- 1:29:59Speaker 1: stage of this. We haven't really worked it out into
- 1:30:03Speaker 1: an effective standard yet. It will come. So people– and
- 1:30:07Speaker 1: the other members of the family get super help. When
- 1:30:08Speaker 1: they all work together and they do it, everybody says
- 1:30:11Speaker 1: I never felt so healthy in my life. Guy Tannenbaum
- 1:30:15Speaker 1: had advanced prostate cancer. He wrote a book and he's
- 1:30:17Speaker 1: on the web and he had hypertension, high blood pressure, overweight,
- 1:30:21Speaker 1: more obesity, everything. And then he does several 18-day water-only fasts,
- 1:30:27Speaker 1: got himself. Everything, all these things went away. His diabetes
- 1:30:31Speaker 1: went away, his hypertension, high blood pressure, and the cancer
- 1:30:34Speaker 1: can't be found. So is he cured? I have no idea.
- 1:30:37Speaker 1: But he's managed? Yes, he's managed. And he's healthier. So
- 1:30:40Speaker 1: what's wrong with that? Isn't that ultimately what medicine wants
- 1:30:44Speaker 1: to do? Keep people alive longer and a healthier quality
- 1:30:48Speaker 1: of life? How many more do we need? They say, oh,
- 1:30:51Speaker 1: that's a fluke. That's a fluke. That's a fluke. That's
- 1:30:53Speaker 1: a fluke. That's a fluke. How many damn flukes do
- 1:30:55Speaker 1: you want?
- 1:30:55Speaker 2: If there's someone listening now, and I'm sure there's going
- 1:30:57Speaker 2: to be many thousands and tens of thousands of people
- 1:31:00Speaker 2: listening that are currently battling cancer, have early stage diagnoses.
- 1:31:06Speaker 1: I know. I feel bad about this because people say, oh,
- 1:31:09Speaker 1: I want to do metabolic therapy. Where can I go?
- 1:31:11Speaker 1: And they go to their local hospital and get slapped down.
- 1:31:13Speaker 1: There's no evidence. Everything that should come out of my
- 1:31:16Speaker 1: mouth has never been taught to me in medical school.
- 1:31:18Speaker 2: So what do you say to those people?
- 1:31:21Speaker 1: You know, I say I'm sorry that the medical establishment
- 1:31:27Speaker 1: has not come to recognize what I'm saying. And then
- 1:31:30Speaker 1: I tell them, right, you know, the change has to
- 1:31:34Speaker 1: be coming from the people. It ain't going to come
- 1:31:35Speaker 1: from the top medical schools. They are doing what they're doing.
- 1:31:39Speaker 1: The status quo is very profitable. The status quo is
- 1:31:43Speaker 1: very effective for these people, but it's not helping the
- 1:31:46Speaker 1: cancer patient as well as it can. And don't forget,
- 1:31:49Speaker 1: we're not throwing out all this stuff. We're just asking
- 1:31:51Speaker 1: people to know how to use the tools we have
- 1:31:53Speaker 1: in a better way. We don't have to throw out immunotherapies, radiation.
- 1:31:57Speaker 1: We don't have to throw out toxic poisons. We just
- 1:32:00Speaker 1: have to know better how to use it when the
- 1:32:02Speaker 1: patient is in this new state. And the data will
- 1:32:04Speaker 1: prove it. But who's going to do that? Who's going
- 1:32:08Speaker 1: to do that? The doctor says, I'd love to do this,
- 1:32:10Speaker 1: but I'm going to lose my license if I do it.
- 1:32:12Speaker 1: What's going on with that? They wrote the standard of
- 1:32:15Speaker 1: care as if it were ingratiated. It can't be changed.
- 1:32:17Speaker 2: No.
- 1:32:18Speaker 1: No. They should be flexible. When new evidence comes up,
- 1:32:20Speaker 1: I don't believe your evidence. What number do you not believe?
- 1:32:23Speaker 1: What piece of science do you not believe on this? Well,
- 1:32:26Speaker 1: I haven't read it. You can't be right when 99%
- 1:32:29Speaker 1: of the world says it's this way and you're saying
- 1:32:31Speaker 1: it's something different. That's confirmation bias. You're not looking at
- 1:32:34Speaker 1: the numbers. And then when they get cancer, you come to, hey,
- 1:32:36Speaker 1: what can you do for me? It's like that. But yes,
- 1:32:41Speaker 1: it has to change. It will change because we're on
- 1:32:43Speaker 1: the momentum to move it. People are coming to know this.
- 1:32:47Speaker 1: And once the change happens, it's going to be like
- 1:32:49Speaker 1: a major, major change. And people are going to have
- 1:32:52Speaker 1: to just readjust.
- 1:32:54Speaker 2: Thomas, we have a closing tradition on this podcast where
- 1:32:56Speaker 2: the last guest leaves a question for the next guest,
- 1:32:58Speaker 2: not knowing who they're going to be leaving it for.
- 1:33:01Speaker 2: And the question that's been left for you is, imagine
- 1:33:05Speaker 2: the end of your life. Your closest friends and family
- 1:33:09Speaker 2: are at your funeral. What do you imagine or hope
- 1:33:12Speaker 2: they say about you?
- 1:33:17Speaker 1: He changed the course of cancer treatment for the world. It,
- 1:33:27Speaker 1: that's it. Dr.
- 1:33:29Speaker 2: Thomas Seyfried, that is exactly what you're doing. And I
- 1:33:34Speaker 2: think that's an extremely, you know, I can't even find
- 1:33:37Speaker 2: a word that describes the profundity of such a mission
- 1:33:41Speaker 2: because so many people are struggling with cancer as if
- 1:33:44Speaker 2: it is this sort of opaque black box of A
- 1:33:47Speaker 2: disease that strikes us at random and picks on people
- 1:33:50Speaker 2: like roulette and debilitates their lives out of the blue.
- 1:33:53Speaker 2: And having more information out there about the root causes
- 1:33:56Speaker 2: of these issues turns the lights on and allows us
- 1:33:59Speaker 2: to go in search of better solutions to what has
- 1:34:02Speaker 2: always been a really, really complex, hard to understand disease.
- 1:34:06Speaker 2: Your work runs almost entirely, I believe, on philanthropic donations, right?
- 1:34:11Speaker 1: That's right.
- 1:34:12Speaker 2: So that's people that.
- 1:34:13Speaker 1: They make donations to both my university, Boston College, which
- 1:34:18Speaker 1: is a Jesuit university in Chestnut Hill, Massachusetts. And we
- 1:34:22Speaker 1: follow the Jesuit philosophy of service to others predominantly. And
- 1:34:27Speaker 1: private foundations.
- 1:34:28Speaker 2: So if someone wants to make a donation, where do
- 1:34:30Speaker 2: they go? Do they go to your website? I know
- 1:34:31Speaker 2: there's a donation button.
- 1:34:33Speaker 1: They go primarily to our university. They can just... On
- 1:34:38Speaker 1: my university biology webpage, there's a donation button. And Travis
- 1:34:42Speaker 1: Christopherson's Foundation for Metabolic Cancer Therapies, which is a 503 foundation,
- 1:34:48Speaker 1: he supports our research through philanthropic donations to his foundation.
- 1:34:53Speaker 2: I would urge anyone that wants to support your mission
- 1:34:55Speaker 2: to go to your university website. There's a donation button there,
- 1:34:59Speaker 2: which I saw earlier on. Click that button and they
- 1:35:01Speaker 2: can make a donation.
- 1:35:02Speaker 1: That's right. And Travis Christopherson's foundation. which is the Foundation
- 1:35:09Speaker 1: for Cancer Metabolic Therapies. It's a 503 foundation, Travis Christopherson's.
- 1:35:15Speaker 1: When people email me, I send them the links to
- 1:35:18Speaker 1: those foundations. I cannot accept personally any money from anybody.
- 1:35:22Speaker 1: That's one thing. That's one thing. I'm not here. So
- 1:35:24Speaker 1: people say, oh, I want to give you money to
- 1:35:26Speaker 1: do it.
- 1:35:26Speaker 2: No, no, no.
- 1:35:26Speaker 1: I can't. You have to give it to the university
- 1:35:28Speaker 1: that comes through me through the appropriate channels to support
- 1:35:31Speaker 1: my research through the university. Dr.
- 1:35:33Speaker 2: Thomas Seyfried, thank you so much for your time today.
- 1:35:35Speaker 2: And I'm hugely inspired and enlightened by everything we've discussed.
- 1:35:40Speaker 2: And I think there's a bunch of very straightforward practical
- 1:35:43Speaker 2: things I'll be implementing in my life, specifically buying one
- 1:35:46Speaker 2: of those bloody machines so that I can keep on
- 1:35:48Speaker 2: my GKI index.
- 1:35:49Speaker 1: Yeah, GKI.
- 1:35:51Speaker 2: GKI index.
- 1:35:52Speaker 1: Yeah, glucose ketone index. Well, listen, thank you very much
- 1:35:54Speaker 1: for having me here because your programs and others alert
- 1:35:59Speaker 1: people to know that there are alternatives. effective alternatives. And
- 1:36:03Speaker 1: once the system changes, the outcomes will not be so
- 1:36:07Speaker 1: bleak as we currently have them today.
- 1:36:15Speaker 2: Isn't this cool? Every single conversation I have here on
- 1:36:19Speaker 2: the Diary of a CEO, at the very end of it,
- 1:36:20Speaker 2: you'll know, I asked the guest to leave a question
- 1:36:24Speaker 2: in the Diary of a CEO. And what we've done
- 1:36:27Speaker 2: is we turned every single question written in the Diary
- 1:36:30Speaker 2: of a CEO into into these conversation cards that you
- 1:36:34Speaker 2: can play at home. So you've got every guest we've
- 1:36:37Speaker 2: ever had, their question, and on the back of it,
- 1:36:40Speaker 2: if you scan that QR code, you get to watch
- 1:36:44Speaker 2: the person who answered that question. We're finally revealing all
- 1:36:49Speaker 2: of the questions and the people that answered the question.
- 1:36:53Speaker 2: The brand new version two updated conversation cards are out
- 1:36:57Speaker 2: right now at theconversationcards.com. They've sold out twice instantaneously. So
- 1:37:02Speaker 2: if you are interested in getting hold of some limited
- 1:37:05Speaker 2: edition conversation cards, I really, really recommend acting quickly.
- 1:37:08Speaker 1: So Thank you.